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G
eneral introduction
For several decades, there has been consensus in scientific literature that chronic 
alcohol use has a neurotoxic effect: it negatively affects brain functioning and 
adaptive behaviour in general (Crews et al., 2005; Harper, 2009; Kalivas & 
Volkow, 2005; McCrady & Smith, 1986; Oscar-Berman & Marinkovic, 2007). 
Neuro psychological studies in patients with alcohol use disorders (AUD) 
demonstrate deficits in attention, memory, and visuospatial functions as well as 
in executive functions such as problem solving, mental flexibility, planning, and 
judgement (Bates et al., 2002; Goldstein et al., 2001; Scheurich, 2005). Consequently, 
treatment components that require these cognitive skills are impeded which 
easily lead to increased drop-out rates (Allen et al., 1997; Manning et al., 2008; 
Scheurich, 2005).
 During abstinence, these alcohol-related cognitive deficits may partly 
recover with a combination of thiamine use and a normal diet (Martin et al., 
2003) and can thus be considered as a dynamic phenomenon during sustained 
abstinence. Indeed, several authors demonstrate that these cognitive deficits are 
(a) to some extent reversible during abstinence (Bates et al., 2002; Fals-Stewart 
et al., 1994; Loeber et al., 2009; Mann et al., 1999), (b) may remain stable over one 
year (Horton et al., 2015; Stavro et al., 2013), and (c) in particular with regard to 
executive functions, may still improve after six years of abstinence (Fein et al., 
2006a; McCrady & Smith, 1986). The speed and extent of recovery differs 
individually depending on age (Goldman, 1983) and time of abstinence (McCrady 
& Smith, 1986).
 Indeed, the alcohol-related cognitive dysfunction must be viewed in the 
context of pre-existing neuropsychological deficits, education level, and pre- 
existing personality traits (Yücel et al., 2007) underscoring the fact that pathways 
leading towards alcohol addiction are complex and difficult to unravel. 
Moreover, it is known that alcohol is a causal factor in the etiology of anxiety 
and depression and that, in turn, the presence of psychopathology and 
personality traits increases the likelihood of alcohol addiction (Verheul et al., 
1999). However, often, the symptoms of psychopathology are related to alcohol 
intoxication and will resolve during abstinence (Becker, 2008; CBO, 2009; Crews 
et al., 2005).
 For Korsakoff’s syndrome (KS) patients, with severe and persistent alcohol 
related cognitive dysfunction, studies have demonstrated structural changes in 
the brain (Martin et al., 2003; Pitel et al., 2014) suggesting that there is a marked 
distinction between KS patients and AUD patients, who typically show less 
severe cognitive deficits or are cognitively unimpaired. In addition, impaired 
social cognition, including social perspective taking and judgement, self-
awareness, and illness insight, has been suggested to play a pivotal role in 
severe alcohol addiction (Uekermann & Daum, 2008; Moeller & Goldstein, 2014). 
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While impaired social cognition is essential for treatment planning and clinical 
management, there it is still little research on this topic. Moreover, the terms 
illness insight, self-awareness, anosognosia, and alcoholic denial are often used 
interchangeably making it difficult to disentangle.
Conceptualisations: Self-awareness, 
anosognosia, illness insight, and denial
Impaired illness insight has historically been termed anosognosia or being without 
knowledge of the disease (Babinski, 1914). Later, this term was used to describe 
the lack of self-awareness for more subtle cognitive impairments (McGlynn & 
Schacter, 1989), the failure of the patient to acknowledge a symptom even when 
confronted by it (Amador et al., 1993), and the inability to accurately estimate one’s 
functional capacity (Prigatano, 2009). Crosson and colleagues (1989) were the first 
to develop a model of insight including three levels of awareness: (1) intellectual 
awareness indicating that patients understand their own limitations; (2) emergent 
awareness indicating that a patient can both recognize his own limitations and is 
able to solve them or compensate for them; and (3) anticipatory awareness, the 
highest level where a patient knows his limitation and makes and carries out a 
plan requiring metacognition and executive functioning skills. Van Schouwen-van 
Kranen (2014) integrated the theoretical model of Crosson (1989) with the cognitive 
disabilities model of Allen et al. (1992) into a clinical reasoning framework in 
traumatic brain injury patients for improving the ability to perform daily tasks. In 
this hierarchy-based model, the level of insight corresponds with the level of 
cognitive functioning, that is from attention (the lowest level), to memory, and 
finally, executive processes (the highest level).
 David (1990) used also as a three level hierarchy-based model distinguishing 
(1) awareness of the illness; (2) the capacity to view symptoms of the disease as 
abnormal; and, ultimately, (3) treatment adherence. In this model, no neuropsy-
chological domains of functioning were described. Phillipi and co-workers 
(2012) in turn described a model of self-awareness which is similar to the model 
of Crosson et al (1989) including: (1) Core self-awareness, a sense of basic 
ownership over actions and sensory representation; (2) Extended self-awareness, 
that is core self-awareness plus the autobiographical self; (3) Introspective self-
awareness, relying on higher order executive, attentional and metacognitive 
functions enabling introspection and ability to reflect on one’s actions. The latter 
is in line with findings of David and colleagues (2012) that introspective 
self-awareness (or illness insight) might range from total denial of the disease to 
more subtle metacognitive awareness deficits.
13
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 In everyday functioning and treatment rehabilitation, impairments in 
illness insight are often seen in patients with neurodegenerative diseases 
(Shany-Ur et al., 2014), traumatic brain injury (Ham et al., 2014), schizophrenia 
(Kruck et al., 2009), and in addiction (Moeller & Goldstein, 2014). In addiction, 
Moeller and Goldstein (2014) define self-awareness as “the failure to ascribe 
personal relevance or significance to internal stimuli or events that have 
implications for the self – be they environmental cues/feedback, interoceptive 
sensations, or on-going behaviour” (p. 1). With this definition, the authors aimed 
to distinguish self-awareness from more specific terms like alexithymia and 
self-consciousness. This means that a patient may have awareness that there is 
a problem, but lacks the (cognitive) skills to seek treatment. 
 Lack of initiative and apathy, often accompanying impaired executive 
functioning, are often found in patients with alcohol-related deficits (Marinkovic 
et al., 2009) and must not be mistaken by a lack of motivation or alcoholic denial 
(Miller & Barasch, 1985; Rinn et al., 2002). Studies demonstrated that alcoholic 
patients underestimate the amount of alcohol they have used (Lincoln et al., 
2011), underestimate the length of their alcohol addiction, and underestimate 
the severe and adverse consequences of alcohol addiction on daily life and 
health functioning (Volkow & Li, 2005). Moreover, studies in patients with 
schizophrenia demonstrate that impaired illness insight is a consequence of 
cognitive dysfunctions (David et al., 2012; Goldstein et al., 2009) and associated 
with impaired verbal memory (Keshavan et al., 2004), lower intelligence (Lysaker 
and Bell, 1994), and executive dysfunction (Drake & Lewis, 2003; Donohoe et al., 
2005). The alcohol-related cognitive disorders complicate treatment utility (Bates 
et al., 2013b) and increase the risk of alcohol relapse (Noël et al., 2002). Cognitive 
deficits reported in chronic alcoholic patients are often subtle in nature and may 
be overshadowed by problems in living and working conditions, parenting 
and/ or social problems, and alcohol-related health issues such as head injury, 
hypertension, blackouts, diabetes, alcohol withdrawal seizures, liver dysfunctions, 
meningitis, hypoglycemia, hepatic encephalopathy and chronic obstructive 
pulmonitis (Brust, 2010; Wekking et al., 2004).
 The aforementioned theories on illness insight and cognitive functioning 
can be integrated into a composite model based on several prior authors (see 
Figure 1). The hierarchy-based model stresses that, although the level of illness 
insight interacts strongly with the level of cognitive functioning, there is a 
gradual transition between the levels of cognitive functions and between the 
levels of illness insight. The highest level of illness insight (e.g., introspective 
self-awareness, anticipatory awareness) in patients with alcohol-related 
cognitive dysfunctions places higher demands on cognitive functioning (e.g., 
intelligence, metacognitive functioning, memory, executive functioning, and 
14
attention) leading to treatment adherence. Based on this thought, a broad 
subdivision in severe, moderate, and mild cognitive impairment seems more 
appropriate. 
Towards a multimethod evaluation of 
alcohol related cognition
The DSM-IV TR (APA, 2000) uses criteria for describing two distinct Alcohol Use 
Disorders (AUD): alcohol abuse and alcohol dependence. However, these labels 
seem to be insufficient to classify the cognitive deficits, which are often found in 
chronic alcoholic patients, possibly resulting in the underestimation of these 
deficits by the clinician. The latter is exactly the issue I want to address in this 
thesis. During neuropsychological assessment of AUD patients, as a crucial 
starting point of treatment planning, a clinician may encounter several issues 
disturbing the clinical picture such as the presence of alcohol-related cognitive 
dysfunctions, the influence of abstinence on the recovery of cognitive functions, 
and the level of illness insight on self-report questionnaires. In this thesis, I aim 
to address the following research questions by means of a multimethod 
evaluation: (1) are alcohol-related cognitive dysfunctions better defined by using 
Figure 1   An integrated hierarchy-based model of illness insight combined with 
the level of cognitive dysfunction for Alcohol Use Disorders (AUD) 
based on Crosson et al. (1986), David (1990), Moeller & Goldstein (2014), 
Philippi et al. (2012), and Van Schouwen-van Kranen (2014).
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the DSM-5 (APA, 2013) compared to the DSM-IV (APA, 2000); (2) what is the best 
timing for conducting a reliable assessment in patients with alcohol- related 
deficits during abstinence; and (3) what is the utility of self-report questionnaires 
and performance tests during abstinence, taking into account that cognitive 
dysfunction and impaired self-awareness might be present.
Objectives and Thesis Outline
In the present thesis, a multimethod evaluation of cognition and illness insight 
is employed in AUD patients by means of the following methods: classification, 
self-report and correction methods, performance tasks and rating scales (self 
and others), as well as a systematic clinician based evaluation. A central theme 
of this thesis is the role of impaired self-awareness in the behavioral and 
cognitive assessment of AUD patients in order to achieve a better treatment 
planning.
 Chapter 2 starts with the investigation how alcohol related cognitive deficits 
are classified according to the DSM-5 (APA, 2013). The conceptualization and 
classification of AUD are discussed in DSM-5 terms, as compared to the DSM-IV 
TR (APA, 2000) and identify the need of a different view on alcohol-related 
cognitive dysfunction in clinical practice. In Chapter 3 reviews the empirical 
evidence on the length of the abstinence time required before a reliable neuro-
psychological assessment of cognitive and emotional functioning of AUD 
patients can be carried out. In Chapter 4 the literature is reviewed with respect 
tot the application of correction methods on the MMPI-2 (Minnesota Multiphasic 
Personality Inventory-2; Butcher et al., 1989), a self-report questionnaire that is 
often used for psychological treatment design in AUD patients. This is important 
for detecting under-reporting tendencies due to impaired self-awareness as well 
as over-reporting tendencies due to alcohol withdrawal during the acute phase 
of abstinence. In Chapter 5, the clinical utility of a specific MMPI-2 correction 
method (Van Balen et al., 1997) is investigated in order to avoid temporarily 
elevations on multiple clinical scales of the MMPI-2 during the acute phase of 
abstinence. To this end, the data of a large group of AUD patients, who were 
assessed after two weeks of abstinence, was used. Chapter 6 reports a study 
comparing the magnitude of self-reported cognitive complaints with 
performance on neuropsychological tasks in two distinct AUD patient groups 
with alcohol-related cognitive dysfunction (including patients fulfilling the 
criteria for Korsakoff’s syndrome and patients with less pronounced cognitive 
deficits) in order to examine the concordance between self-reported cognitive 
complaints and performance on intelligence and memory tasks. In Chapter 7 the 
16
reliability, validity and clinical utility of a rating scale is examined compared 
with self-report (i.e., the Q8; Bourgeois et al., 2002a; Bourgeois et al., 2002b) in the 
assessment of impaired self-awareness in AUD. Finally, Chapter 8 provides a 
summary of the study results described in this thesis along with a discussion of 
the limitations. Clinical implications are discussed, in particular with regard to 
the contribution to the advancement of individual treatment planning in AUD 
patients. The chapter ends with perspectives for future research on the 
intersection of diagnostic assessment and clinical management of alcohol related 
cognitive disorders. 
17
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Chapter 2
Alcohol-related cognitive
impairment and the DSM-5
A step towards a better classification 
of alcohol-related cognitive impairment?
Translated and adapted from: 
Walvoort, S.J.W., Wester, A.J., Doorakkers, M.C., Kessels, R.P.C., Egger, J.I.M. 
(2016). Alcoholgerelateerde cognitieve stoornissen in de DSM-5. 
Tijdschrift voor Psychiatrie, 58, 397-401.
20
Abstract
Classification of alcohol-related cognitive impairments in the DMS-IV-TR terms 
is difficult and, as a result, cognitive deficits may be easily overlooked. The 
DSM-5 incorporates the category “neurocognitive disorders”, which may be an 
important improvement in clinical practice. Aim was to compare the DSM-IV-TR 
and DSM-5 with respect to alcohol-related cognitive dysfunction. The clinical 
utility of the DSM-5 is discussed, we systematically compared the chapters of 
the DSM-IV-TR for alcohol-related cognitive impairments and describing the 
changes that have been incorporated in the DSM-5. Results show that DSM-5 
puts a greater focus on alcohol-related cognitive impairment. In addition to a 
distinction in severity (major or minor neurocognitive disorder), a distinction is 
made between a non-amnestic and an amnestic-confabulatory type, while 
symptom duration can be specified (behavioral disorders and/or persisting). 
In all, alcohol-related neurocognitive dysfunction is described more extensively 
in the DSM-5 than it was in the DSM-IV-TR, with an essential role for neuro-
psychological assessment for the classification, diagnosis, and treatment of 
neuro cognitive deficits.
21
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Introduction 
For several decades it has been convincingly shown that chronic alcohol use 
may lead to cognitive disorders (Bates et al., 2002). Specifically, an alcohol intake 
of more than 21 units a week already constitutes a risk factor for the development 
of cognitive dysfunction (Jue & Schilt, 2009). In patients with Korsakoff’s 
syndrome the impairment is evident and memory deficits, executive problems, 
and the associated changes in personality (such as apathy and behavioral 
problems) are easily recognized. However, the cognitive impairments often 
reported in patients with persistent AUD, are more subtle in nature and may go 
unnoticed, as they can be overshadowed by problems in living, work, or 
relationship. Alcohol-related cognitive dysfunction varies from mild to severe 
problems in attention, memory, visuospatial, and executive functions (including 
planning and organization abilities, cognitive flexibility, decision-making, and 
working memory) and social-cognitive functions (CBO, 2009; Wester & Kessels, 
2012). Alcohol-related dysfunction complicates treatment (Bates et al., 2013b; 
Bruijnen et al., 2013), increases the risk of alcohol relapse (Noël et al., 2002), and 
is difficult to classify with the DSM-IV-TR (APA, 2007). The question is whether 
the DSM-5 (APA, 2014) puts a greater focus on these alcohol-related cognitive 
dysfunction and how they can best be classified. In the present article we 
describe how alcohol-related cognitive deficits are classified in the DSM-IV-TR 
and compare this to the perspectives the DSM-5 offers.
Alcohol-related cognitive disorders as classified in the DSM-IV-TR
In the DSM-IV-TR a distinction is made between alcohol use disorders (AUD) 
and disorders resulting from alcohol use (alcohol-induced disorders). The first 
group comprises alcohol misuse/abuse and alcohol dependence, while the 
second group includes intoxication, withdrawal, delirium, persisting dementia, 
persisting amnestic disorder, psychotic disorder, mood disorder, anxiety 
disorder, sexual dysfunction, and sleeping disorders. Cognitive disorders are 
preferentially diagnosed by means of neuropsychological examination after an 
abstinence period of at least six weeks (Walvoort et al., 2013).
 According to the DSM-IV-TR, severe, persisting alcohol-associated cognitive 
disorders (Korsakoff’s syndrome) are classified as “alcohol-induced persisting 
amnestic disorder” (code 291.1). This classification has the drawback that it stresses 
the amnestic component even though also substantial executive dysfunctions 
have been demonstrated in patients with Korsakoff’s syndrome (e.g., Van Oort & 
Kessels, 2009). The DSM-IV-TR additionally offers the classification “alcohol- 
induced persisting dementia” (code 291.2) when multiple cognitive deficits and 
severe limitations in daily functioning are present. The criteria for alcohol- 
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related dementia (Oslin et al., 1998) state that none of the cognitive deficiencies 
may be attributable to delirium, substance-induced intoxication, or withdrawal. 
Moreover, the term dementia may be confusing because it is often associated 
with an underlying neurodegenerative process whereas, following sustained 
abstinence from alcohol, the cognitive dysfunctions tends to stabilize or may 
even improve to some extent (Stavro et al., 2013). In the Dutch guidelines on 
 alcohol-related disorders (CBO, 2009) it is even proposed to refrain from using 
the term “alcoholic dementia” to describe the syndrome because of the lack of 
scientific evidence of a direct causal relationship between alcohol abuse and 
dementia.
 The diagnosis of “alcohol dependence” (code 303.90) is relevant in the case 
of chronic alcohol use in the absence of Korsakoff’s syndrome. If neuro-
psychological assessment reveals neurocognitive impairment, the classification 
“cognitive disorder- NOS” (code 249.9) is to be added. Although the combination 
of both classifications do capture the severity of the addiction and cognitive 
dysfunction, the nature and the extent of the latter symptoms, which neuro-
psychological domains of functioning are affected, or the implications for treatment 
remain unclear.
Alcohol-related cognitive disorders and their classification  
according to the DSM-5
In the DSM-5 alcohol addiction (alcohol use disorder) is part of the major group 
of  “substance-related and addictive disorders” (e.g., Van den Brink, 2014). Although 
alcohol- associated cognitive disorders are briefly mentioned here, one is 
primarily referred to the separate subcategories “substance/medication-induced 
major or mild neurocognitive disorder,” of the main category of “neurocognitive 
disorders.” Apart from alcohol- induced cognitive disorders, this broader 
category also includes the “old” DSM IV-TR classifications delirium, dementia, 
and cognitive disorders-not otherwise specified. The DSM-5 states that these 
neurocognitive disorders need to be acquired, resulting in a decline in cognitive 
functioning. A severity distinction is made in terms of “major” and “minor” 
neurocognitive disorders, where this subdivision indicates that the DSM-5 
views neurocognitive deficits and the resulting impairments in daily functioning 
as a continuum (Simpson, 2014). 
 Major neurocognitive disorders needs to be associated with a significant 
decline (>2 SDs below the age- and education-corrected mean) in one or more 
cognitive domains relative to a previous level of functioning, which is preferably 
determined by neuro psychological testing. It manifestly affects daily functioning 
in the absence of a delirium or another mental disorder such as depressive 
disorder or schizophrenia. It can further be verified whether the symptoms are 
23
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associated with behavioral disorders, whose current severity can be quantified 
(mild, moderate, or severe). 
 Mild neurocognitive disorders are characterized by a mild decline (between 
1-2 SDs below the mean) in one or more cognitive domains relative to a previous 
level of functioning that causes minimal to no limitations in daily life. It is 
appended that, although the independent performance of activities of daily 
living as such is not affected, it may require more effort, compensating strategies 
or adjustments. Also with mild neurocognitive impairments one can specify 
whether they involve behavioral disorders and whether the cognitive deficits are 
persisting following continued sobriety.
 Korsakoff’s syndrome, then, is to be classified as “major neurocognitive 
disorder, amnestic-confabulatory type” (code 291.1). Depending on the severity 
of the observed cognitive deficits in non-Korsakoff patients, a subdivision is 
made into “major neuro cognitive disorder, non-amnestic-confabulatory type” 
(code 291.2) and “minor neuro cognitive disorder” (code 291.89), where, in 
addition to the classification “neurocognitive disorder”, the classification “severe 
alcohol use disorder” applies (code 303.90). 
 To elucidate neurocognitive problems, the DSM-5 offers an extensive 
description of the neurocognitive domains of functioning, including attention, 
executive functions, learning and memory, language, perceptual-motor and so-
cial-cognitive functions. Per domain, a distinction is made between major and 
mild neurocognitive impairments with examples of symptoms or observations 
being given. Although no concrete references are made to specific neuropsycho-
logical tests, the examples provide clear clues to neuropsychological diagnostic 
procedures with which abovementioned neurocognitive dimensions can be 
assessed. 
Discussion and conclusion
With the introduction of the DSM-5, neurocognitive dysfunction resulting from 
chronic alcohol use can be better classified than was the case with the previous 
version, the DSM-IV-TR. The DSM-5 distinguishes “major” from “minor” 
neurocognitive disorders, thus regarding neurocognitive deficits and their 
severity as a continuum (Simpson, 2014). This perspective emphasizes the 
relevance of neuropsychological assessments in the diagnosis and classification 
of alcohol-induced neurocognitive dysfunction. Despite the consideration the 
DSM-5 gives to neurocognitive disorders, it remains, above all, a classification 
system. While its classifications facilitate the identification of cognitive deficits, 
it is neuropsychological testing that will provide invaluable information about 
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the suspected neuropsychological domains of functioning. Based on these test 
results, an analysis of strengths and weaknesses can be made from which the 
following treatment phase can be directed and tailored, guiding the choice of 
interventions (e.g., behavioral approach, skills training, or a directive approach). 
This will prevent patients from being overestimated by the therapist during 
treatment, which will reduce the risk of dropout (Crews et al., 2005; Fals-Stewart 
& Shafer, 1992). 
 Neurocognitive dysfunction may already be detected during the first contact 
by using brief screening tools, of which the Montreal Cognitive Assessment 
(MoCA; Nasreddine et al., 2005) is a good example. The MoCA has already been 
applied in alcohol-dependent patients (Alarcon et al., 2015), addicted patients 
(Bruijnen et al., 2013; Copersino et al., 2009), and patients with Korsakoff’s 
syndrome (Oudman et al., 2014). This brief cognitive screener helps to detect 
signs of cognitive problems, and provides indications for further examination. 
As the MoCA comes in three parallel versions, the course of the cognitive 
functions can be monitored during treatment. By screening patients in an early 
stage, interventions can be modified to take these cognitive deficits into account, 
which might otherwise hamper successful treatment. 
25
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Chapter 3
Neuropsychological assessment 
and alcohol abstinence
Translated and adapted from: 
Walvoort, S.J.W., Wester, A.J., Egger, J.I.M. (2013). Neuropsychologische 
diagnostiek en cognitieve functies bij alcoholabstinentie. Tijdschrift voor 
Psychiatrie, 55, 101-111.
28
Abstract
There is a vast amount of scientific evidence for the negative effects of alcohol on 
the functioning of the whole human body and particularly of the brain. The 
literature, however, is unclear about whether these functions can fully recover 
and about how long the abstinence period must be before patients with alcohol 
use disorder (AUD) can be reliably assessed with respect to cognitive and 
emotional functioning. Aim of the present chapter was to review current 
findings on the length of the abstinence period required before a reliable neuro-
psychological assessment can be carried out in AUD patients. Using PubMed, 
Psycinfo and Medline, we consulted the literature for the period from 1975 to 
October 2011 relating to the effects of alcohol abstinence on the brain. Results 
show that the longer the period of abstinence, the greater the improvement in a 
patient’s neuropsychological functioning. In the case of AUD patients, it takes at 
least six weeks for neuropsychological functioning to return to a fairly stable 
level. In conclusion, an abstinence period of at least six weeks is required before 
a reliable neuropsychological assessment can be carried out. This time period 
minimizes the disturbance caused by earlier alcohol abuse. The six-week period 
of abstinence is recommended as a guideline for AUD patients if they are to 
undergo appropriate and individualized neuropsychological assessment.
29
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Introduction
Alcohol addiction is the most prevalent of all addictions among the general 
population of substance users (CBO, 2009). There is broad consensus in today’s 
scientific literature that alcohol affects brain functioning. Neuroimaging 
research on alcohol-dependent patients shows (a) loss of cerebral volume 
associated with cognitive decline and behavioral change (Crews, 1999; 
Oscar-Berman & Marinkovic, 2003); (b) dysfunction of the hippocampus, frontal 
cortex, basal ganglia, cingulate gyrus, cerebellum, and their interconnections 
(Bühler & Mann, 2011; Demirakca et al., 2011; Moselhy et al., 2001; Oscar-Berman 
& Marinkovic, 2003; Scheurich, 2005); and (c) lesions in the anterior thalamic 
nuclei (e.g., in Korsakoff’s syndrome; Bodani et al., 2009). After several months of 
abstinence the loss in cerebral volume may partially or even fully be restored 
due to white matter remyelination (Oscar-Berman et al., 1997). Both animal and 
human experimental studies found evidence of cell proliferation in the 
hippocampus during abstinence (Nixon & Crews, 2004; Nixon, 2006; Gazdzinski 
et al., 2008). From the sixth week of abstinence, apart from improved liver functions 
(CBO, 2009), significant reductions in the volume of cerebrospinal fluid and the 
size of ventricular cavities are described (Bartsch et al., 2007; Wobrock et al., 
2009), which may develop from improved protein synthesis, dendrite growth 
(Geller, 1991), or blood flow and rehydration (Wobrock et al., 2009). 
 An alcohol intake of more than 21 units a week already constitutes a risk 
factor for the development of cognitive impairment (Jue & Schilt, 2009), with 
symptoms manifesting in mild to severe attention deficits (reduced alertness 
and attention span, heightened distractibility, and impaired sustained and 
divided attention), episodic memory dysfunction (reduced learning, storage and 
retrieval), visuospatial impairment (diminished visuospatial information 
processing), and motor deficits. Also executive dysfunction can be present, 
which may include impaired planning, organization, and control, reduced 
flexibility in thinking, impaired decision making, reduced working memory 
(affecting the temporary maintenance of information) and disinhibition. Verbal 
intelligence and semantic memory remain relatively intact (Bates et al., 2002; 
Goldstein et al., 2001). Additionally, chronic alcohol use may also result in 
deficits in social cognition (cognitive processes involved in emotion processing 
and social interactions) affecting judgement and illness insight (Uekermann & 
Daum, 2008). 
 It is known that cognitive deficits and personality changes will to some 
extent “disappear” after an abstinence period of several weeks to months 
provided there is no serious secondary or comorbid pathology as optimal 
recovery would then require more than 12 months (Bates et al., 2002; Bühler & 
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Mann, 2011; CBO 2009; Fein et al., 2006a; Fein et al., 2009; Schuckit, 2005; Sullivan 
et al., 2000a; Van Holst & Schilt, 2011). This implies that test results obtained in 
too early a stage of abstinence might be obscured by the effects of alcohol on 
brain functioning, withdrawal symptoms, and the on-going recovery of 
cognitive functions (Banken & Greene, 2009; Chanraud et al., 2007; Loeber et al., 
2009; Mann et al., 1999; Rosenbloom & Pfefferbaum, 2008). These factors need to 
be taken into account to prevent mere temporary effects of alcohol withdrawal 
from being measured. Neuropsychological assessment can detect cognitive 
impairments to help optimize the following treatment phase (Schrimser & 
Parker, 2008).
 Notwithstanding the scientific consensus on the associations between 
alcohol and negative brain effects, findings are mixed when it comes to the 
period of abstinence required to allow reliable conclusions about a patient’s 
current level of cognitive and emotional functioning. In clinical practice the 
decision when to test, that is, either at an early or a later stage of abstinence, can 
be a source of tension given that delaying assessments will increase the clinic’s 
waiting-list period. Also, as tests administered in the acute phase of abstinence 
will show the effects of alcohol withdrawal rather than the level of cognitive 
functioning, a too early assessment may lead to clinical misinter pretation. 
 To investigate these issues, the present paper reviews all systematic studies 
on the relevance of neuropsychological assessment in abstinent AUD patients, 
the duration of abstinence at the time of testing, the effects of abstinence on 
cognitive functioning, and factors complicating neuropsychological assessment. 
Method
Our review of the literature started with a search of the Dutch guidelines on 
disorders in alcohol use (CBO, 2009) and textbooks on psychiatry and (neuro)
psychology (e.g., Lishman, 2009; Deelman et al., 2006; Lezak et al., 2012; Butcher, 
2009). As none made mention of abstinence durations, we subsequently extended 
our search to include the PubMed, PsychINFO, and Medline search engines 
covering the period between 1975 up to October 2011 using the search terms 
alcohol AND abstinence in combination with the terms cognitive, recovery, neuro-
psychological, and assessment. Having also examined the reference lists of relevant 
articles, we next made a selection of the resulting literature on the basis of the 
following inclusion criteria: 
1. Studies needed to describe the recovery mechanisms of the brains of adult 
(> 18 years) alcohol-abstinent patients (N > 10) from a neurological and a 
neuropsychological perspective;
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2. Studies needed to report multiple assessments conducted during the acute 
stages of alcohol withdrawal or have performed neuropsychological assessment 
after six weeks of abstinence. 
Studies investigating other substance use disorders in combination with alcohol 
dependence and case studies were not included in this review. 
Results
Our literature search yielded 28 references for Alcohol AND Abstinence AND 
recovery AND cognitive, 37 references for Neuropsychological AND Abstinence 
AND recovery, and 4 references for Assessment AND Abstinence AND recovery. 
Overlapping studies were excluded, leaving 19 studies for this review. 
Relevance of neuropsychological assessment
Various studies convincingly demonstrated the value of neuropsychological 
assessment in recovering AUD patients to determine individualized treatment 
interventions and most distinctly so for seemingly symptom-free patients who 
only showed subtle executive dysfunctions when having to learn new skills. 
Allowing for these latent, individual deficits will increase the chance of treatment 
success (Davies et al., 2005; Schrimsher & Parker, 2008). With their study, Crews 
et al. (2005) underscored that recovery of executive functions is the key to 
successful treatment outcome. Arguably, these findings suggest that, from a 
didactical viewpoint it is insufficient to offer interventions comprising psy-
cho-education, verbal group therapy, relapse prevention, social skill training, 
motivational interviewing, system therapies, or complex weekend planning 
schemes in the early stages of alcohol abstinence (Allen et al., 1997; Schrimsher 
& Parker 2008). Many of these psychosocial programs rely on intact cognitive 
abilities to understand, process, and retain the (verbal) information provided, 
where it has been shown that cognitive deficits correlate positively with 
treatment dropout (Fals-Stewart & Schafer, 1992). Bates and colleagues (2005) 
accordingly propose to save such more complex elements of the intervention 
that require abstraction reasoning and information processing capacities for a 
later stage, that is, after one to two months of abstinence. It is therefore essential 
that neuropsychological assessment is conducted prior to any treatment as, 
apart from delineating cognitive impairment, it will also uncover the patient’s 
strengths, allowing interventions to be tailored to the individual.
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The duration of abstinence before assessment
Although the relevance of neuropsychological assessment in abstinent AUD 
patients is widely supported, until now, there is no academic consensus as to 
their optimal timing. Sherer et al. (1984) posit that a ten-day abstinence should 
be sufficient to rule out any withdrawal effects. Other researchers suggest an 
abstinence of three to four weeks before psychiatric diagnoses can be performed 
(Bradizza et al., 2006). Essentially in line with this, the Dutch multidisciplinary 
guidelines on disorders of alcohol use (CBO, 2009) cautiously suggest an interval 
of two to three weeks before depressive or anxiety disorders can be reliably 
assessed, while adding that in the majority of AUD patients symptoms of 
depression and anxiety largely disappear spontaneously after one to four weeks. 
Lezak and colleagues (2012) note that during the first two weeks of abstinence 
most AUD patients display neuropsychological symptoms, with recovery of 
cognitive functions being most pronounced after the first week and the optimum 
recovery becoming manifest in weeks three to six. However, the effects of 
alcohol on the executive functions appear not to have improved sufficiently after 
three weeks of abstinence (Cordovil De Sousa et al., 2010; Van Holst & Schilt, 
2011), while having had multiple withdrawals may result in more severe 
executive deficits (Scheurich, 2005).
 In conclusion, the recommended abstinence before neuropsychological 
assessment varies between 10 and 42 days in the literature, with recovery 
mechanisms playing a major role in this wide time range. In the next section we 
will expand on the influence of abstinence on cognitive functioning.
Effects of abstinence on the cognitive abilities of AUD patients
Various studies show that cognitive and emotional symptoms improve as a 
consequence of abstinence, with some reporting full recovery within several 
weeks (Leber et al., 1981; Mann et al., 1999) and others not until several months 
(Fein et al., 1990; Sullivan et al., 2000b; Sullivan et al., 2000c). Others argued that 
cognitive functions do not fully recover even after years of abstinence (Brandt et 
al., 1983; Fein et al., 2006a). Bartels and colleagues (2007) propose that, when 
studying functional recovery in abstinent AUD patients, a distinction needs to 
be made between the acute phase, in which withdrawal symptoms coincide with 
the recovery of functions following abstinence, and a much more prolonged 
phase of functional/morphological regeneration during which relapses may delay the 
cognitive recovery process. If abstinence is maintained, recovery of cognitive 
functions may even continue for up to two years. 
 During alcohol intake the ‘alcoholic brain’ undergoes compensation-orient-
ed changes whereby more and other areas need to be activated than is the case 
in healthy controls, which goes at the cost of accuracy and speed of information 
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processing (Rosenbloom & Pfefferbaum 2008). Functions that are affected in the 
acute stages of abstinence are processing speed, verbal episodic memory, 
working memory, nonverbal reasoning, visuospatial perception, and executive 
functioning (see Table 1). Davies and co-workers (2005) suggest that the observed 
memory problems may be (at least partially) explained by underlying deficits in 
attention and concentration. In their respective studies, Zinn et al. (2004) and 
Manning et al. (2008) observed signs of executive dysfunction in abstinent AUD 
patients up until six weeks after alcohol withdrawal. Both research teams, 
however, remark that the instruments they used to evaluate executive functions 
may lack ecological validity (2008). 
 Besides cognitive improvement, research has found evidence of positive 
changes in emotional functioning during abstinence. Comparing the profiles of 
AUD patients on the clinical scales of the Minnesota Multiphasic Personality 
Inventory (MMPI) obtained shortly after admittance to the clinic and after 30 
days of abstinence, Dush and Keen (1995) recorded significant MMPI scale 
reductions. Allen (1996) accordingly recommended postponing MMPI 
assessment until after the patient’s condition has stabilized. In the acute phase of 
abstinence amelioration of emotional symptoms coincides with a lessening of 
withdrawal symptoms such as irritation, agitation, anxiety, sleep disturbance, 
anhedonia, and pain (Becker, 2008; Schuckit, 2009). Lincoln and colleagues (2011) 
recently demonstrated how cognitive dysfunction influences the outcomes of 
self-report questionnaires. They found that AUD patients found it difficult to 
make an accurate estimation in the first six weeks of abstinence of the quantity 
of alcohol they had consumed before admission to a clinic, which is attributable 
to deficits in memory functioning caused by chronic alcohol use.
Factors complicating neuropsychological assessment 
Several potentially confounding factors need to be considered when interpreting 
neuropsychological assessment results during abstinence following chronic 
alcohol use. The risk of health problems such as head trauma, hypertension, 
black-outs, diabetes, alcohol withdrawal seizures, liver dysfunction, meningitis, 
hypoglycemia, hepatic encephalopathy, and chronic obstructive pulmonary 
disease (COPD; in combination with tobacco use) increases with the number of 
years of chronic drinking (Brust, 2010; Wekking et al., 2004), while all conditions 
can affect outcomes, as will persistent symptoms associated with depressive, 
mood and anxiety disorders. Other factors of influence are the age of the patient 
(Munro et al., 2000), the use of other substances (polydrug use, medication), and 
comorbid personality disorders. 
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Table 1   Studies examining the effect of abstinence on the recovery of  
cognitive functions in AUD patients
Author(s) Sample Abstinence period Cognitive domain/ MRI Findings
Bartels et al., 2007 N=50 (30 with amnesia,  
11 non-amnesic; 9 multi-domain)
T1: 2 a 3 weeks
T2: 3, 6, 12, and 24 months; N=32
Visuo-spatial, verbal comprehension, attention, 
verbal and non verbal memory
Amnesia: ↑
Non-amnesic and multidomain: ≠
Bartsch et al., 2007 N=15 T1: at admission 
T 2: > 6-7 weeks 
Attention, MRI. Brain volume: ↑ attention: ↑
Bates et al., 2005 N=169  
(alcohol and drugs)
T1: at admission 
T2: > 6 weeks
Verbal comprehension, attention, executive 
functions, processing speed, and verbal memory.
Memory: ↑
Other functions: ≠
Bendszus et al., 2001 N=17 
N=12 controls
MRI 
T1: 1-3 days
T2: 36-39 days
NPO > 20 days
MRI and MR spectroscopy 
Intelligence, attention, verbal memory
Correlation between brain volume and cognitive 
performance 
Brandt et al., 1983 N=134
N=76 controls
3 groups:
1-3 month
1-3 year
>5 year
Memory, visuospatial Improvement after 1 year. Long term memory: ≠
Cordovil De Sousa Uva  
et al,. 2010
N=35 
N=22 controls
T1:1-2 days 
T2: 14-18 days 
Attention, executive functions EF: ≠
Davies et al., 2005 N=43
N=58 controls
T1 > 6 weeks Processing speed, verbal comprehension, visuo-
spatial, verbal memory, and attention 
Prefrontal functioning, attention, and processing 
speed: ≠
Dush & Keen 1995 N=525 T1: 1-2 days
T2: 30 days
Emotional functioning All Clinical scales: ↓, clinical Scale 4: ≠
Fein et al., 2006 N=48 T1: > 6 year Premorbid intelligence, visuospatial, attention, 
processing speed, and executive functions
Visual organisation: ≠,  
other functions: ↑
Gazdzinski et al., 2008 N=13 + smoking and N=11 – smoking T1: 1 week
T2:> 1 month
MRI Smoking has adversive effects on medial temporal 
lobe functioning
metabolic: ↑
Leber et al., 1981 N=32 
N=16 controls
T1: 3 weeks
T2: 11 weeks
Non-verbal memory At T2: some recovery of cognitive functioning. 
Possibly right hemisphere deficits.
Mann et al., 1999 N=49 
N=49 controls
T1: at admission
T2: > 5 weeks
Attention, verbal memory, and premorbid 
intelligence.
T1: 5 of 12 tasks: ↓
T2: in 4 of these 5 tasks: ↑
Verbal short term memory: ≠ 
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The question remains whether persistent cognitive dysfunction points to a 
condition resulting from the patient’s chronic alcohol use or to a pre-existing 
susceptibility to alcoholism (van Holst & Schilt, 2011). A premorbid vulnerability 
due to genetic or environmental factors, education, gender (Hopenbrouwers et 
al., 2010), and a vulnerability of the brain to alcohol in combination with the 
toxic effect of alcohol, will contribute to the severity of the cognitive dysfunction. 
Moreover, indirect effects of alcohol play a role, such as other organ failure and 
traumatic brain injury. Indisputably, complex interactions of (potentially) mutually 
reinforcing factors are present. Aside from these factors and associations, it has 
been shown that repeated episodes of binge drinking (periods during which 
large volumes of alcohol are consumed within a short space of time) and having 
undergone more than two detoxifications will cause permanent neurological 
damage to the brain resulting in persistend neurological impairment, or 
contributing to dementia (Becker 2008; Brust, 2010; Duka et al., 2003). 
 Even though the nature and severity of pathology may differ widely 
between patients, routine neuropsychological evaluation after a fixed term of 
abstinence is highly recommended. Complementing diagnostic examinations, 
auto-anamnesis, hetero-anamnesis, careful history taking, and scrutiny of 
Table 1   Continued
Author(s) Sample Abstinence period Cognitive domain/ MRI Findings
Manning et al., 2008 N=30 T1: 4 days
T2: 26 days
Premorbid intelligence
Verbal and nonverbal memory, executive 
functions
Working memory: ↑ 
Flexibility/ planning): ≠ 
Munro et al., 2000 N=36 (55-83 year) N=18: 1 month-6 months
N=18 > 6 months
Visuo-spatial, verbal comprehension, attention, 
memory, and executive functions
Memory and executive functions: ≠
Rourke & Grant 1999 N=35 T1: 7-21 days
T2: 125-133 days
Attention, visuospatial, and verbal memory Recovery correlates with aging, abstinence and 
interim relapse 
Schrimsher & Parker 
2008
N=58
(N=15 alcohol; N=43 poly)
T1: at admission
T2:> 24 days
Attention, language, memory Memory and attention: ↑
Sullivan et al., 2000 N=42 T1: 1month
T2: 2 months
T3: 12 months
Non verbal memory, attention, visuospatial, 
coördination
Significant improvement between T1 and T3.
Wobrock et al., 2009 N=56 
N=45 controls
T1: at admission
T2: 6 months
T3: 9 months
MRI: specific 
Volumes lateral ventricles and pre frontal cortex
T1: prefrontal cortex: ↓, ventricles: ↑
T2 en T3: ventricle volume: ↓
Zinn et al., 2004 N=27
N=18 controls
T1:1-58 days Verbal comprehension, attention, non-verbal and 
verbal memory, executive functions
Executive functions: ≠
Memory: ↑
Note. ↑= improvement; ↓= deterioration; ≠ = no improvement/ no deterioration.
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self-reported and previous clinician-recorded medical histories that allow a 
good overview of the patients’ problems and social environment, neuropsycho-
logical assessment affords a reliable comparison of data serving both research 
and clinical purposes. 
Discussion and conclusion
In the majority of recovering people with alcohol use disorder, cognitive 
performance improves in proportion to the length of alcohol abstinence, with 
empirical findings indicating that recovery to a relatively stable condition tends 
to take three to five weeks. This applies in particular to verbal skills and 
visuospatial abilities while executive functions (problem-solving abilities and 
learning) take longer to recover.
 It is noteworthy that in the current literature the main focus is on psychiatric 
and psychotherapeutic approaches. This carries the risk that treatments 
will predominantly be symptomatic, given that withdrawal phenomena and 
complicating factors will stand out. If (residual) cognitive deficits that will be 
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different for each recovering patient are not detected, there is the additional risk 
of overestimating the patient by the therapist (Crews et al., 2005). 
 As early as in 1981, Leber et al. concluded that the duration of abstinence 
is a crucial variable where neuropsychological outcomes are concerned. The 
current literature is still at odds as to the timing of neuropsychological 
assessment in abstinent AUD patients. While some studies report full or 
clinically significant recovery of cognitive functions within a few weeks, others 
do not observe any actual functional improvement until years later or note no 
improvement at all. There is consensus in regard to the positive effects of 
adequate nutrition and thiamine replacement on the recovery of cognitive and 
emotional symptoms and the presence of alcohol-induced cognitive deficits 
influencing treatment success. 
 Detailed neuropsychological assessment of patients with AUD is a 
prerequisite for effective, personalized treatment. Given the state of the art in 
the field, an abstinence period of at least six weeks is recommend to guarantee 
reliable neuropsychological assessment outcomes, where recovery of liver and 
other organ functions is crucial (Gazdzinski et al., 2008; Geller, 1991; CBO, 2009; 
Wobrock et al., 2009). During this six-week interval, the brain is allowed to 
regenerate, preventing unnecessary disturbance of the clinical picture and the 
associated risk of inadequate treatment interventions. Concerning the present 
findings future research should aim at relationship between somatic and neuro-
psychological markers.
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Chapter 4
Assessment of psychopathology 
and personality with the MMPI-2 
in patients with alcohol use 
disorder (AUD): Should we not 
correct for associated cognitive 
dysfunctions?
Published as: 
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pathology and personality with the MMPI-2 in patients with alcohol use 
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Abstract
Treatment planning of Alcohol Use Disorders (AUD) patients is often preceded 
by the assessment of psychopathology and personality with the Minnesota 
Multiphasic Personality Inventory (MMPI-2). However, in the acute phase of 
abstinence, both physical and cognitive problems can cause temporary elevations 
on multiple clinical scales of the MMPI-2 resulting in inadequate interpretation 
and treatment planning. Over the past years, several correction procedures 
were developed to correct for these problems in different neurological disorders, 
but until this date, there are no published data available on correction procedures 
for AUD patients. An extensive literature search is performed in Pubmed, 
Medline, and Psychinfo for the period from 1975 through 2011 resulted in 
thirty-five studies on MMPI (-2) correction procedures typically developed for 
neurological patient groups. Review of the literature demonstrates that, given 
the similarity of cognitive deficits in patients with AUD and in those with 
Traumatic Brain Injury (TBI), the use of an MMPI-2 neurocorrective procedure 
may be helpful to avoid over-interpretation of psychopathology and personality 
profiles during the acute phase of abstinence and to formulate more adequate 
treatment planning. Further empirical research should focus on the development 
and validation of such a neurocorrective procedure, that specifically addresses 
the alcohol-induced cognitive symptoms during the acute phase of withdrawal.
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Introduction
It is common practice to assess emotional functioning in patients with Alcohol 
Use Disorders (AUD) and to use this information in the process of treatment 
design and planning. To this end, often, the Minnesota Multiphasic Personality 
Inventory-2 (MMPI-2) is applied. The MMPI-2 is internationally the most widely 
used self-report questionnaire for the assessment of personality and psycho-
pathology (Butcher, 2006). It is well known that individuals who enter substance 
abuse treatment centres, often experience emotional discomfort and distress as 
part of their multi-problem crisis. Such a crisis nearly always precedes admission 
to an addiction clinic (Becker, 2003; Bartels et al., 2007; Schuckit, 2009) and is 
associated with elevations on multiple clinical scales of the MMPI-2 (Forbey & 
Ben-Porath, 2007). 
 During the process of abstinence, withdrawal of alcohol can lead to a variety of 
physical, emotional, and cognitive complaints. The physical symptoms disappear 
within days whereas the cognitive, emotional, and motivational deficits, caused 
by the neurotoxic effect of alcohol, tend to persist during several weeks after 
admission (e.g., Becker, 2008).
 Several reports of cognitive dysfunctions are found in patients with AUD, 
including deficits in memory, executive attention, planning, the processing of 
environmental feedback, working memory, and response inhibition (Goldstein 
et al., 2001; Scheurich, 2005; Loeber et al., 2009). Also, a gradual decline of social 
and emotional functioning is described, for example in the studies on personality 
change by Bates, Barry, and Bowden (2002), and Scheurich (2005). This is in line 
with studies demonstrating the toxic effect of alcohol on brain functioning and 
adaptive behaviour in general (Allen et al., 1997, Moselhy et al., 2001; Crews et al., 
2005; Davies et al., 2005; Kalivas & Volkow, 2005; Oscar-Berman & Marinkovic, 
2007; Schuckit, 2009). 
 To some extent, cognitive functions recover during abstinence (Mann et al., 
1999; Martin et al., 2003; Sullivan & Pfefferbaum, 2005; Manning et al., 2008). 
This recovery process can last up to several years (Bates et al., 2002; Fein et al., 
2006a). Withdrawal symptoms can influence the response pattern on self-report 
questionnaires in such a way that the level and pattern of scale-scores leads to 
clinical misinterpretation (Johnson-Greene et al., 2002). Dush and Keen (1995) 
found that over 30 days of abstinence, the overall elevation of MMPI clinical 
scales in AUD patients tended to decline and the profiles became less distinctive. 
This is in accordance with MMPI and MMPI-2 studies on patient groups with 
neurological deficits, where the influence of psychological disturbance leads to 
unreliable scores and wrong treatment indication (Alfano et al., 1993; Van Balen 
et al., 1997; Van Balen et al., 1999). 
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 In order to deal with the influence of cognitive deficits on the MMPI, and 
later on the MMPI-2, several correction procedures were developed for different 
neurological disorders over the past years. These correction procedures are 
based on the identification of neurologically relevant items (NRI’s), which refer 
to neurological symptoms, like attention problems, headache, nausea, physical 
discomfort, and loss of energy. These symptoms are also observed in AUD 
patients during abstinence (Becker, 2008). Although there is a remarkable 
similarity between the neuropsychological profile of patients with chronic 
substance abuse and that of patients with mild traumatic brain injury (MTBI; 
Lange et al., 2008), until this date, no studies on correction procedures in AUD 
patients were found, and no systematic research has been conducted to the use 
of MMPI-2 correction procedures in AUD patients during abstinence. 
 Therefore, the aim of this study is to review the clinical relevance of using 
correction procedures in AUD patients during the acute phase of abstinence. 
Given the long tradition of MMPI and MMPI-2 research in AUD patients, the 
most relevant findings on alcohol related profiles will be summarized first.
The MMPI -2 in the assessment of AUD patients
The MMPI-2 is a self-report questionnaire with 567 statements to be answered 
with True or False. The MMPI-2 can be administrated with individuals who are 
at least 18 years old and have at least a sixth grade level of reading ability. After 
scoring by hand or computer, the individual’s profile can be compared with 
profiles from the normative sample (Butcher, 2006). In the development of the 
MMPI-2, apart from the MacAndrew Alcoholism Scale Revised (MAC-R; 
MacAndrew, 1965) that was already part of the original MMPI, two novel 
substance abuse scales were added: the Addiction Potential Scale and the 
Addiction Admission Scale (APS; AAS; Weed et al., 1992). However, since our 
main focus is the correct assessment of psychopathology in AUD patients, the 
specific investigation of these alcoholism scales is beyond the scope of this 
article. For further reading, see Banken and Greene (2009).
 Most of the MMPI and MMPI-2 studies investigate the clinical scales by 
their elevations and code types, as described by Graham (2006). Although it is 
clear that there is no unique alcohol personality in AUD patients (Banken & 
Greene, 2009), code types are used to identify, in a quick way, AUD patients with 
similar treatment needs in improving treatment outcome (Allen, 1996). Graham 
and Strenger (1988) found, in their review of the use of the MMPI in AUD 
patients, that the most consistent finding between alcoholic and non-alcoholic 
patients was a high score on clinical scale 4, which is quite stable over time, but 
not unique to AUD patients only. Egger and co-workers (2007) distinguished 
three types of alcohol dependence: (a) the antisocial, immature, risk-taking type; 
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(b) the negativistic, alienated, schizoid type, and (c) the anxious, passive, 
introverted type. In this study it was pointed out, however, that such a distinction 
is not independent of other psychological and cognitive deficits during 
abstinence, for example inhibitory dysfunctions. On the other hand, a study 
with Korsakoff Syndrome patients demonstrated low psychopathology and 
undisturbed personality patterns on their “flat” MMPI-2 profile, indicating the 
illusion of a problem free and well-adjusted patient group. The authors 
emphasized the need for further investigation into the lack of (illness) insight 
that accompanies several neuropsychiatric and neuropsychological phenomena 
(Egger et al., 2002).
 Other studies identified the code type 2-4/ 4-2 (Schroeder & Piercy, 1979; 
Graham & Strenger, 1988; Johnson et al., 1992; Lesswing & Dougherty, 1993; 
Donovan et al., 1988) indicating psychopathic deviation, acting out behaviour, 
and a negative treatment attitude. However, the MMPI was administered in the 
first two weeks after admission, where the influence of detoxification can affect 
its outcome. The latter is convincingly demonstrated in the study by Dush and 
Keen (1995) where the typologies of AUD patients directly after admission and 
after 30 days of treatment were investigated. The authors found a dramatic 
overall reduction in pathology on all clinical scales, with the exception of clinical 
scale 4. They concluded that the MMPI typology itself does not remain stable 
due to influence of treatment, detoxification over 30 days, the passage of time 
(from the crisis environment), and regression to the mean. 
 In short, during the acute phase of abstinence, the AUD patient is hampered 
by cognitive disturbances due to influence of withdrawal of alcohol, which in 
turn might be reflected on the MMPI-2 scales. It will take at least six weeks 
before there is a recovery of functioning to a somewhat stable level in AUD 
patients. Bates and co-workers (2002) found that the level of neuropsychological 
functioning will increase with the length of the abstinence period, because 
during such a period, the brain will have time to regenerate (Geller, 1991; 
Gazdzinski et al., 2008; Wobrock et al., 2009). 
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Method
An extensive literature search was performed in Pubmed, Medline, and 
Psychinfo for the period from 1975 through October 2011. On each of the combined 
search terms Alcohol AND Neurocorrection, Abstinence AND Neuro correction, 
Alcohol AND Neurologically Relevant Items, Abstinence AND Neurologically 
Relevant Items, no articles were found. In the absence of such studies, the 
usefulness of existing MMPI-2 correction procedures, originally developed for 
neurological patient groups, is examined. Therefore, each of the combined 
search terms MMPI* AND Neurocorrection, MMPI* AND correction, MMPI* 
AND neurologically relevant items, MMPI* AND correction procedure, and 
MMPI* AND Neurologic were used to search the Psychinfo, Pubmed, and 
Medline database (Table 1).
 Only studies on MMPI and MMPI-2 correction procedures, their clinical 
relevance, and studies that commented these procedures, were included. Studies 
on K-correction were excluded. Twenty-seven articles matched the criteria and 
eight studies were added by reference and citation analysis. A total of thirty-five 
articles were studied. 
Table 1   Search terms and hits in Pubmed, Psychinfo and Medline
Search term Pubmed Psychinfo Medline
MMPI* AND neurocorrection 2 (2) 0 (2) 2 (2)
MMPI* AND correction 13 (74) 17 (67) 11 (161)
MMPI* AND Neurologically relevant items 2 (3) 2 (2) 2 (3)
MMPI* AND correction procedure 7 (27) 3 (15) 3 (15)
MMPI* AND neurologic 9 (74) 5 (71) 7 (171)
Remaining articles without overlap 27
Additional articles by reference and citation analysis 8
Total studied articles 35
Note. MMPI= Minnesota Multiphasic Personality Inventory. In parentheses the amount of articles, in bold 
the amount of articles who met the criteria of the current study.
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Results
MMPI-2 and correction procedures
Baldwin (1952) was one of the first to apply a correction procedure in patients 
with Multiple Sclerosis (MS). MMPI items, which refer to neurological symptoms, 
were removed before scoring. In the development of correction procedures, 
different names were used for items, which refer to a neurological content. For 
convenience, the current study uses the term neurologically relevant items 
(NRI’s). Besides the development of correction procedures in patients with MS 
(Meyerink et al., 1988; Nelson et al., 2003), procedures were developed in different 
patient groups, including epilepsy (Derry et al., 1997; Nelson et al., 2004), cerebro-
vascular disease (Gass, 1992), stroke (Gass & Lawhorn, 1991; Gass, 1996), spinal 
cord injury (SCI; Kendall et al., 1978; Rodevich & Wanlass, 1995; Barncord & 
Wanlass, 2000), obstructive sleep apnea (Gale et al., 1999), and traumatic brain 
injury (TBI; Alfano et al., 1990; Alfano et al., 1993; Cripe et al., 1995; Gass & Wald, 
1997; Van Balen et al., 1997). A correction procedure involves constructing a set 
of neurologically relevant items contained within existing personality or 
emotional scales that measures neurologic dysfunction. The effects of these 
NRI’s are thus separated out and examined independently of emotional 
functioning. In this way, purer estimates of cognitive and emotional functioning 
can be obtained in groups of brain-damaged individuals (Nelson & Cicchetti, 
1995).
 Correction procedures are available for the MMPI, the MMPI-2, and the 
MMPI-2 short form. The procedures differ in the amount of a) NRI’s that are 
endorsed; b) in the way these NRI’s are selected, and c) how they are implemented 
in the scoring procedure.
Although several procedures have been developed for comparable patient 
groups, there are differences in the amount of NRI’s that were identified (see 
table 2). For instance, in TBI patients, Alfano et al (1990) identified 44 NRI’s. In a 
follow up study, 13 NRI’s were derived from these 44 NRI’s (Alfano et al., 1993). 
Gass (1991) identified 14 and 15 NRI’s for the MMPI-2 short form. Gass and 
Russell (1991) identified 42 NRI’s, Artzy (in Brulot et al., 1997) identified 18 NRI’s, 
and Van Balen et al (1997) identified 24 NRI’s. In using a correction procedure 
both the MMPI and the MMPI short form are used, explaining some of the 
differences in the amount of the NRI sets. However, the main difference is 
explained by the methodology used to identify items in both patients with TBI 
and patients with epilepsy, multiple sclerosis, stroke, and spinal cord injury.
Most of the correction procedures are based on the clinical experience of medical 
specialists, familiar with neurological patient groups. These specialists were 
asked to identify items in the MMPI booklet, which reflect neurologic symptoms 
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that can be viewed as part of the illness. Based on the degree of agreement 
between the specialists, items were included in the correction procedure 
(Meyerink et al., 1988; Alfano et al., 1990; Gass & Russel, 1991; Alfano et al., 1993; 
Rodevich & Wanlass, 1995; Van Balen et al., 1997; Barncord & Wanlass, 2000; 
Table 2   Summary of MMPI-2 correction procedures and associated clinical scales
Patient 
group
Authors Number 
of NRI’s
Method Deleted/ 
prorated
Form Affected  
clinical scales
Epilepsy Derry  
et al., 1997
19 Empirical Deleted MMPI-2 1, 2, 3, 7, 8
Epilepsy Nelson  
et al., 2004
25 Combined: 
statistical and 
empirical
Deleted MMPI-2 1, 2, 3, 8
MS Baldwin,  
1952
12 Empirical Deleted MMPI 1, 2, 3, 8
MS Meyerink  
et al., 1988
30 Empirical Deleted MMPI 1, 2, 3, 8
MS Nelson  
et al., 2003
19 Statistical Deleted MMPI-2 1, 2, 3, 8
SCI Barncord and 
Wanlass, 2000
49 Empirical Deleted MMPI-2 1, 2, 3, 7, 8
SCI Kendall  
et al., 1978
10 Statistical Deleted MMPI 1, 2, 3, 4, 8
SCI Rodevich and 
Wanlass, 1995
28 Empirical Deleted MMPI-2 1, 2, 3, 7, 8
Stroke Gass, 1992 21 Statistical Prorated MMPI-2 
short form
1, 2, 3, 7, 8
TBI Alfano  
et al., 1990
44 Empirical Deleted MMPI 1, 2, 8
TBI Alfano  
et al., 1993
13 Empirical Deleted MMPI 1, 2, 8
TBI Artzy, 1994 18 Statistical Deleted MMPI-2
TBI Gass and 
Russell, 1991 
42 Empirical Prorated MMPI 1, 2, 3, 7, 8
TBI Gass, 1991 14 Empirical Prorated MMPI-2 
short form
1, 2, 3, 7, 8
TBI Gass and Wald, 
1997
15 Statistical Prorated MMPI-2 
short form
1, 2, 3, 7, 8
TBI Van Balen  
et al., 1997
24 Empirical Prorated MMPI-2 1, 2, 3, 7, 8
Note. MMPI= Minnesota Multiphasic Personality Inventory, MS= Multiple Sclerosis, NRI= Neurologically 
Relevant Items, SCI= Spinal Cord Injury, TBI= Traumatic Brain Injury.
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Derry et al., 2002). There is a difference in the amount of specialists who were 
questioned, ranging from two (Meyerink et al., 1988; Derry et al., 1997; Barncord 
& Wanlass, 2000; Derry et al., 2002) through 40 (Van Balen et al., 1997).
 Other authors used a statistical procedure to select NRI’s by comparing the 
scores of neurological patients with the scores of a normative group. Items were 
only included in the procedure if they were statistically different. For instance, 
Kendall and colleagues (1978) used factor analysis to differentiate between SCI 
patients and a matched non-hospitalised control group. Nelson and colleagues 
(2004) used a combined statistical and empirical procedure in order to enhance 
the validity of MMPI-2 in patients with epilepsy. In their study, a board-certified 
epileptologist analysed each MMPI-2 item and selected 15 items, which reflect 
the symptoms of epileptic seizures. The statistical procedure distinguished 13 
items from epilepsy patients with normal controls. The combined statistical and 
empirical procedure identified 25 NRI’s. In another study, in patients with MS, 
Nelson and colleagues (2003) used a procedure consistent with that used by 
Gass (1992) and Gass and Lawhorn (1991) in their MMPI-2 correction studies. 
This correction procedure involves the following steps: 1) identification of items 
endorsed by more than 25% of patients with MS; 2) statistical analysis to 
determine which items significantly differentiated patients with MS from 
controls, and 3) to determine item inter relatedness.
 The correction depends on the responses of the patient to the 14 items. As a 
result, the amount of items can vary, ranging from none to substantial. On the 
other hand, Artzy (in Brulot et al., 1997) compared item endorsement frequency 
of persons with closed head injuries with persons of the normative sample. Item 
responses frequencies were contrasted between normals and patients. Items 
that statistically discriminated between normals and patients were included in 
the correction procedure. Sixty items were found, that differentiated between 
head injured patients and the normative group; Eighteen items differentiated 
between the head injured group and patients with chronic pain. In the 
development of this procedure, Artzy followed the “empirical keying” method 
of the MMPI to select the NRI’s. However, in the application of such a procedure 
there is a chance that items are included in a correction procedure that 
statistically differentiate between groups, but have no relation to the theoretical 
construct being studied, as demonstrated by LaChapelle and Alfano (2005). This 
underscores the importance of a sound theoretical basis in obtaining the proper 
neurological items. 
 Another important finding is the way the correction procedures are 
implemented in the scoring procedure. In some studies on correction procedures, 
the NRI’s must be deleted before scoring (Kendall et al., 1978; Alfano et al., 1990; 
Alfano et al., 1993; Artzy (in Brulot et al., 1997); Derry et al., 1997; Nelson et al., 
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2003; Nelson et al., 2004). Some authors recommend to score the MMPI twice, 
corrected and uncorrected, to specify the minimum and maximum limits for 
the patient on each of the affected scales (Kendall et al., 1978; Alfano et al., 1993). 
Van Balen et al., (1999) identified 24 NRI’s, in TBI patients, by comparing the 
normative sample with the correction procedures rescored (NRI’s scored in a 
pathological direction were rescored in the non pathological direction) and 
prorated (a statistical correction adopted from Gass and Russell (1991) to avoid 
overcorrection). In the NRI-prorated procedure, within each scale, the prorated 
raw score is estimated by 
(1) NNe + ( PNe × NNe / NN )
where NNe is the number of Non-NRI endorsements, PNe the patient’s NRI 
endorsement, and NN the total number Non-NRI endorsements. 
 Although there is a broad variety of correction procedures in different 
patient groups, they correspond strongly to the way they act on the clinical 
scales. All correction procedures reduce the level of pathology on clinical scales 
1, 2, and 8 to distinguish physical from psychological complaints, in order to 
make a more reliable diagnose regarding emotional disorders (Table 2). Most of 
the correction procedures reduce the level of pathology on clinical scales 1, 2, 3, 
7, and 8, because these clinical scales contain the most neurological relevant 
items (Cripe, 1989; Gass, 1991).
Validity and clinical utility of the correction procedures 
Since the development of MMPI correction procedures, several validity studies 
were published in order to evaluate its use in clinical practice. Several critiques 
pointed at the fact that these procedures assume the profiles of neurologic 
patients to be relative homogeneous, that correction procedures lack specificity 
for neurological impairment, and that they compromise the integrity of the 
MMPI as such (Cripe et al., 1995; Arbisi & Ben-Porath, 1999; Edwards et al., 2003). 
Also, Greene et al (1997) criticized the correction procedures for their poor 
empirical validity and advised clinicians to be cautious in using these sets of 
correction items until they have been validated empirically across several 
settings. Moreover, Cripe et al (1995) suggest that any given item of the MMPI 
may be endorsed for a variety of reasons and that resulting scale elevations for 
two individuals can be the same for different reasons. 
 Replication studies, such as Dunn and Lees-Haley (1995) found that only 5 
of the 14 NRI’s, identified by Gass (1991), discriminated significantly between 
head-injured and non head-injured patients in a forensic setting. However, the 
correction effect is not clinical significant. Smith and Heilbronner (2000) used 
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these NRI’s in a sample of mild TBI patients in litigation and concluded that 
patients are more likely to endorse anxiety and cognitive disturbances early on 
after the injury. With time, they report fewer of these symptoms. This is in line 
with the findings that NRI’s reflect acute neurologic symptoms that are likely to 
resolve following mild head injury (Rayls et al., 1997; Rayls et al., 2000).
 Glassmire et al (2003) investigated three correction procedures (Alfano et 
al., 1993; Gass, 1991; Gass & Wald 1997) on sensitivity and specificity. They found 
a strong sensitivity in discriminating Closed Head Injury (CHI) patients from 
normal individuals, but a poor specificity when discriminating CHI from 
psychiatric patients. These findings are not surprisingly, since in most psychiatric 
patients severe cognitive deficits are found. Brulot, Strauss, and Spellacy (1997) 
compared the correction procedures developed by Alfano (Alfano et al., 1993), 
Artzy (in Brulot et al., 1997), and Gass (1991) in patients with suspected head 
injury. The authors found that the NRI’s lack discriminant validity. Edwards 
and colleagues (2003) compared three correction procedures (Meyerink et al., 
1988; Alfano et al., 1990; Gass, 1991) and concluded that these three correction 
procedures are not specific in distinguishing patients with closed head injury 
and psychiatric patients, it undermines the statistical integrity of the MMPI, and 
the meaning of scale elevations are less clear after correction. However, in 66% 
of their sample, no information is present regarding premorbid psychiatric 
functioning, or drug and alcohol abuse. Patients were administrated ranging 
from 1 month to 7 years following suspected head injury, while it is well known 
that the symptoms of acute neurologic consequences of mild head injury are 
likely to resolve after 3-6 months post injury (Rayls et al., 2000). In a replication 
study of the 44 NRI’s identified by Alfano et al (1990), Hamilton et al (1995) found 
evidence that these NRI’s discriminate between neurological and non-neurolog-
ical groups. In addition, the authors suggest that in head-injured patients, 
emotional manifestations are more likely to be expressed in terms of cognitive, 
somatic, or behavioural dysfunction, caused by a lack of insight or other 
cognitive impairments resulting from brain damage, trouble expressing 
appropriate affect, decreased levels of arousal, or location of maximal damage. 
The latter implies that the danger of over scoring psychopathology in 
neurological patient groups remains when using the MMPI-2. This is in line 
with the recommendations of Hayes and Granello (2009), in their study with 
patients with MS, to score the MMPI-2 twice (with and without neurocorrec-
tions) to note differences that may be based on physical symptoms. Also, they 
recommend the use of a clinical interview that highlights MS symptoms to 
increase the effectiveness of MMPI-2 assessment in treatment planning.
Arbisi and Ben-Porath (1999) stated that, in order to obtain an accurate measure 
of psychopathology, the NRI’s must be scored in a different direction (prorated). 
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Also a cautious clinical application of the correction procedure is recommended, 
especially when using the MMPI-2 to assess the presence of affective disturbance 
following head injury. Therefore, the authors emphasize the importance of 
investigating the predictive validity of corrected and uncorrected profiles for 
the improvement of reliable and valid MMPI-2 assessment in neurological 
patient groups in the future.
Discussion and conclusion
In clinical practice, the MMPI-2 can be a helpful instrument in the assessment of 
emotional functioning in patients with cognitive, emotional and motivational 
deficits and pre-existent personality factors (Arbisi & Ben-Porath, 1999). 
However, during early abstinence, uncorrected MMPI-2 scales tend to reflect 
symptoms of withdrawal and cognitive recovery thus leading to overestimation 
of levels of psychopathology. Given the close similarity between TBI patients, in 
the early phase of recovery, and AUD patients, in the acute phase of abstinence, 
it is remarkable that, until now, no research has been conducted in which 
MMPI-2 typologies of AUD patients have been examined as to the validity of 
their interpretation when a neurobehavioural correction procedure would have 
been applied. This undocumented aspect of assessment in patients with AUD 
should be addressed in clinical research, particularly because both cognitive 
and emotional factors play an important role in the understanding of the 
patient’s self-reported condition and of its course during abstinence. 
 The effects of abstinence and cognitive recovery on multiple scales of the 
MMPI-2, can easily lead to inadequate treatment planning, resulting in a more 
symptomatic approach. Such an approach (e.g. verbal group therapy for 
depression or anxiety, and long psychotherapeutic sessions) is inadequate 
because it ignores the underlying cognitive deficits during the acute phase of 
abstinence and increases the risk of drop-out (Crews et al., 2005) even in 
apparently “clinically healthy” abstinent AUD patients (Davies et al., 2005). 
Allen (1996) concluded in his study, that repeating the MMPI during treatment, 
could assist in planning later treatment stages. He also recommends the delay of 
testing until the patients’ condition has been stabilized after detoxification. This 
is in line with the findings of Dush and Keen (1995) where all clinical scales 
declined, except for clinical scale 4, over a period of 30 days of abstinence. 
Although one could argue that MMPI-2 assessment should be postponed until 
most symptoms are in remission, clinically, the early availability of information 
on psychological and socio- emotional functioning is of great importance to 
effective treatment design. 
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 Everything leads to the conclusion that detection of cognitive deficits is of 
major importance to the design of proper treatment strategies and to the 
maximisation of its outcome and not to rely on one measure only (Allen et al., 
1997; Davies et al., 2005; Scheurich, 2005). Currently, a forthcoming study on the 
effect of neurobehavioral correction on MMPI-2 profile configuration of AUD 
patients, shows that uncorrected profiles in AUD patients tend to overestimate 
the levels of psychopathology; and underrate levels of disinhibitory behaviours 
and impulsive traits, leading to diagnostic drift and inadequate treatment 
planning (Walvoort et al., 2012). In this study, only the correction effects on the 
clinical scales were investigated. It is well known that the clinical scales have an 
item overlap and consist of demoralisation items. For instance, clinical scales 2 
and 7 contain items to be related to anxiety, depression, and other emotional 
distress, assessing more demoralization than personality, psychopathology 
(Graham, 2012). In order to avoid item overlap and to reduce demoralization, the 
MMPI-2 Restructured Clinical (RC) scales were developed (Tellegen et al., 2003). 
Recent studies of Van der Heijden and co-workers (Van der Heijden et al., 2008; 
Van der Heijden et al., 2010) indicate that the RC scales have a better internal 
consistency and a lower scale level intercorrelation than the clinical scales and 
as a result provide a higher density of information. 
 Another promising development in the assessment of AUD patients and 
neurological patients is the MMPI-RF. The MMPI-RF is shorter, is based on the 
RC-scales and has new scales for both somatic and neurological complaints. 
Recent research demonstrates also meaningful relations between the MMPI-RF 
and the Temperament and Character Inventory (TCI; Van der Heijden et al., 
2013a), the Millon Clinical Multiaxial Inventory- III (Van der Heijden et al., 
2012a), and in relation to DSM IV (Van der Heijden et al., 2013b). Until now, there 
are no studies on correction procedures and its impact on RC-scales or the 
MMPI-RF scales. Validation studies are needed in order to justify this 
non-standard scoring procedure. Especially in forensic and litigation procedures, 
where clinicians are bound by standard assessment protocols. Future research 
on the interplay between personality and cognition and validation studies of 
MMPI-2 correction procedures are needed to address this issue. 
 The current review stipulates that in the acute phase of abstinence, a 
correction procedure is necessary to avoid misinterpretation of complaints 
leading to inadequate treatment planning. Along with the withdrawal effects of 
alcohol, AUD patients also have problems in social cognition (self-awareness 
and illness insight) caused by the toxic effect of chronic alcohol use (Oscar-Berman 
& Marinkovic, 2007). Recent evidence suggests that alcohol related impairments 
in emotional functions, may be observed when the cortico-limbic circuitry is 
unable to compensate for the hypo-activity of the amygdala, resulting in 
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continued alcohol abuse and a wide array of behavioural problems including 
disinhibition, impulsivity, and interpersonal difficulties (Marinkovic et al., 
2009). In addition, other aspects of neuropsychological functioning will affect 
the clinical scales during MMPI-2 administration, including understanding 
the MMPI-2 statements, the level of difficulty of the statements (e.g. double 
negatives), and reduced mental effort (e.g. sustained attention, working memory 
capacity, information processing speed, and decision making). Moreover, a 
study with a homogeneous group of Korsakoff patients, found deficits in a story 
comprehension task specifically caused by executive dysfunction (Oosterman et 
al., 2011). That cognitive dysfunction can influence self-report is also shown in a 
recent study with alcohol dependent patients by Lincoln and colleagues (2011). 
They found impairments in the estimation and self-evaluation of past alcohol 
intake that could be attributed to verbal memory dysfunctions contingent upon 
chronic alcohol abuse. These studies suggest that AUD patients are both 
hampered by the somatic complaints and cognitive deficits during abstinence. 
Although it is clear that the somatic complaints “disappear” during abstinence 
(Becker, 2008), the influence of the alcohol related cognitive deficits (e.g. executive 
functioning, social cognition and memory) on the MMPI-2 may be greater than 
expected.
 This review supports the thought that, in order to acquire a sound diagnostic 
MMPI-2 profile in AUD patients, an MMPI-2 correction procedure is necessary. 
In developing such a correction procedure, the following steps will be required: 
First, a theoretical framework must be given, in which the correction items 
reflect the alcohol-induced cognitive deficits during abstinence. Second, the use 
of a pro-rated procedure is necessary in maintaining the statistical procedure of 
the test. Third, validation studies are needed to investigate the utility in clinical 
practice.
 In conclusion, when AUD patients are assessed in the acute phase of 
abstinence, the application of an MMPI-2 correction procedure may be of critical 
relevance for the correct interpretation of the psychopathology and personality 
profile. From there on, adequate and individualized treatment planning requires 
repeated evaluation of a patients’ emotional and cognitive functioning. 
Further investigations should focus on the development and validation of the 
aforementioned correction procedure and on its relation with cognitive recovery.
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Chapter 5
Neurocognitive parameters 
should be incorporated in the 
MMPI-2 assessment of patients 
with alcohol use disorders
Published as: 
Walvoort, S.J.W., Wester, A.J., Egger, J.I.M. (2012). Neurocognitive parameters 
should be incorporated in the MMPI-2 assessment of patients with alcohol use 
disorders. Drug and Alcohol Review, 31, 550-557.
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Abstract
Treatment planning for Alcohol Use Disorder (AUD) patients is often preceded 
by the assessment of psychopathology and personality with the Minnesota Multi - 
phasic Personality Inventory (MMPI-2). However, during periods of abstinence, 
cognitive impairments (e.g., attention, memory, and executive dysfunctions) 
related to neurological and somatic pathology may affect level and pattern of 
MMPI-2 scale-scores, resulting in clinical misinterpretation. A re-analysis of the 
data of the Egger et al study (2007) is conducted in order to examine the clinical 
significance of the MMPI-2 profiles of 222 AUD patients (mean age 42.2 ± 
9.6 years; 76.6% men) by using Neurological Relevant Item (NRI) correction 
procedures. Hierarchical cluster analyses of NRI-corrected solutions were 
compared to the original MMPI-2 profile. 
 Results show that impulsiveness and psychopathic deviation were identified 
as a common denominator and that uncorrected MMPI-2 assessment in AUD 
tends to overstress psychopathology and to overlook disinhibitory traits in early 
abstinence, caused by chronic alcoholism. 
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Introduction
For decades, it is reported that personality traits are important predictors both 
of treatment success and treatment drop-out in patients with Alcohol Use 
Disorders (AUD) (Crews et al., 2005; Müller et al., 2008). As a consequence, it is 
common practice to assess personality traits in AUD patients and to use this 
information in the process of treatment design and planning. For such an 
assessment of personality traits, often, the Minnesota Multiphasic Personality 
Inventory-2 (MMPI-2) is used. The MMPI-2 is the most widely used self-report 
questionnaire for the assessment of emotional functioning (Butcher, 2006).
 With respect to patients with AUD, several studies with the original MMPI 
tried to define typologies or ‘code types’ of AUD patients (Graham & Strenger, 
1988; Donavan et al., 1989; Johnson et al., 1992; Lesswing & Dougherty, 1993). 
These code types are still reported to be valid, despite the thorough revision that 
the MMPI has undergone for the construction of the MMPI-2 (Graham, 2006). 
In their MMPI-2 typology study of AUD patients, Egger et al., (2007) differentiated 
three types of alcohol dependence: (a) the antisocial, immature, risk-taking type, 
(b) the negativistic, alienated, schizoid type, and (c) the anxious, passive, 
introverted type. Although they found evidence for convergent validity with 
measures of temperament and character, they nevertheless concluded that 
cluster differences may have been influenced by cognitive deficits during 
abstinence (e.g., inhibitory dysfunctions). While MMPI-2 assessment is still 
standard procedure in many clinical settings, there is scarce evidence for the 
treatment utility of this diagnostic approach, that is, for the degree to which this 
form of diagnostic assessment enhances treatment outcome (Sher et al., 2005; 
Nelson-Gray, 2003). One possible explanation for poor outcome is that underlying 
cognitive features can affect the endorsement of items from a self-report 
questionnaire in such a way that the level and pattern of scale-scores leads to 
clinical misinterpretation (Johnson-Greene et al., 2002). This is in accordance 
with the fact that there is a growing body of evidence that the chronic use of 
alcohol influences brain functioning and adaptive behaviour in general (Crews 
et al., 2005; Allen et al., 1997; Davies et al, 2005; Kalivas & Volkow, 2005; Moselhy 
et al., 2001; Oscar-Berman & Marinkovic, 2003; Oscar-Berman & Marinkovic, 
2007; Schuckit, 2009). 
 Indeed, several reports of cognitive dysfunctions are found in patients with 
AUD, including deficits in memory, executive attention, planning, the processing 
of environmental feedback, working memory, response inhibition (Goldstein 
et al., 2001; Loeber et al., 2009; Scheurich, 2005), and a gradual decline of social 
and emotional functioning (Scheurich, 2005; Bates et al., 2002). All lead to the 
conclusion that detection of cognitive deficits is of major importance to the 
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design of proper treatment strategies and to the maximisation of its outcome 
(Scheurich, 2005; Allen, 1996).
Recovery during abstinence
Although some cognitive functions will be permanently affected by chronic 
alcohol abuse, not all of them are irreversible. Manning and colleagues (2008) 
describe AUD patients who after a longer period of abstinence show a gradual 
improvement of executive functioning. They conclude that, shortly after 
admission, a treatment program will easily outweigh the patient’s cognitive 
capacities, whereas later on, when executive functioning, attention, memory 
and planning have gradually improved, patients may be more responsive to 
such a treatment program.
 This is in line with studies who found a significant recovery of functions 
after detoxification Mann et al., 1999; Martin et al., 2003). Bates et al. (2002) point 
out that some functions return after several weeks, but others can take years to 
recover. A study on cognitive performance on long-term abstinent AUD patients 
(average period of abstinence = 6.7 years) reveals the recovery of most of the 
cognitive functions, except the spatial information processing ability (Fein et al., 
2006a). Recovery of executive functioning is seen as the key towards a successful 
treatment (Crews et al., 2005). Moreover, in AUD patients assessed with the 
MMPI and the Halstead-Reitan Neuropsychological Test Battery, a strong 
relationship was demonstrated between emotional distress (anxiety and 
depression) and executive functioning due to frontal lobe dysfunction common 
to cognitive and affective domains (Johnson-Green et al., 2002).
Apart from cognitive functioning, several studies also point at the partial 
recovery of emotional and somatic functioning. Dush and Keen (1995), for 
instance, found that AUD patients, who were retested 30 days after inpatient 
treatment, showed a dramatic overall reduction in pathology and presume this 
to be due to the influence of toxicity and exaggerated symptomatology in the 
first month of abstinence. Other authors have suggested to view the consequences 
of AUD as a special form of traumatic brain injury (TBI) (Lange et al., 2008; Lee 
et al., 2008). Reitan and Wolfson (1997), in their review on emotional disturbances 
and interaction with neuropsychological deficits, indeed found that head injured 
patients who recovered on neuropsychological functions, also demonstrated 
MMPI-“recovery,” i.e., decrease in profile level. In contrast, patients with serious 
cognitive deficits continued to demonstrate deviant profiles. This corroborates 
the findings of Johnson-Greene et al (2002) who noted that in some of these 
patients, the MMPI may be measuring the severity of brain dysfunction rather 
than their emotional distress, and suggests a replication with the MMPI-2. 
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 The above studies underscore the scientific prudence that is needed in the 
interpretation of self-reports made by AUD patients. Nevertheless, it would be 
highly beneficial when a clinician, in the early phases of treatment, could have 
measures of both cognitive and emotional functioning at his disposal.
Neurobehavioural correction
In order to cope with the emotional and cognitive disturbances that may hamper 
adequate assessment, and to increase the validity of the MMPI-2 interpretation, 
several correction procedures were developed over the years and used in 
different patient groups on the MMPI (Hamilton et al., 1995; Gass, 1992) and, 
later, on the MMPI-2 (Gass, 1992; Gass & Wald, 1997; Barncord & Wanlass, 2000; 
Van Balen et al., 1997). The Dutch adaptation of the MMPI-2 (Derksen et al., 2006) 
provides a so-called neurological filter (Neurologically Relevant Items; NRI’s) 
for patients with damage to the central nervous system. The authors describe 
the NRI’s as items “related to symptoms associated with the direct sequelae of 
neurological pathology, such as lack of energy, muscle paralysis, slowness of 
information processing, trouble in concentrating or memory disorders” (Van 
Balen et al., 1997). The NRI’s contain items about symptoms related to attention, 
concentration, headaches, dizziness, visual difficulties, pain, mobility, nausea 
and loss of energy, the typical symptoms that AUD patients experience during 
withdrawal of alcohol. The physical symptoms tend to disappear within days, 
while the psychological distress symptoms take more time (Becker, 2008). 
 Van Balen and colleagues (1997) identified their NRI’s by asking a group of 
40 experts (10 neuropsychologists, 10 neurologists, 10 psychiatrists and 10 
physiatrists), who were familiar with brain damaged patients, for their opinion 
on MMPI-2 statements in three patients groups, i.e., patients with TBI, stroke, 
and whiplash. For the whole group, 48 NRI’s were found of which 26 were 
specific for the whiplash group, 25 for the stroke group and 24 for the TBI group. 
The latter group was studied in more detail by comparing the item endorsements 
of the TBI patients with those in the normative sample. The TBI protocols were 
then scored using both the rescored correction procedure (NRI’s scored in a 
pathological direction were rescored in the non-pathological direction) and the 
prorated correction procedure (a statistical correction adopted from Gass & 
Russell (1991) to avoid overcorrection). It was concluded that in the acute phase 
of TBI, a prorated correction procedure is the preferred choice. The 24 NRI’s load 
on clinical scales 1, 2, 3, 7 and 8, content scales HEA and WRK. This is in line 
with findings where the clinical scales 1, 2, 3, 7 and 8 have been identified as 
containing the most neurological relevant items (Gass & Russel, 1991). The 24 
NRI correction has proven to be a reliable and valid tool in studies with 
brain-damaged patients (Van Balen et al., 1999). 
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 In spite of its relevance for assessment practice, until now, no research has 
been conducted in which MMPI-2 typologies of AUD patients have been 
examined as to the validity of their interpretation when a neurobehavioural 
correction procedure would have been applied. This is a remarkable lack in 
clinical knowledge, particularly because both cognitive and emotional factors 
play an important role in the understanding of the patient’s self-reported 
condition and of its course during abstinence. Unfortunately, while the NRI 
correction procedure was not available at the time, the original study of Egger et 
al (2007) does not address the difference in uncorrected and corrected profiles. 
However, re-analysis of its data would enable the study of the clinical significance 
of the MMPI-2 neurobehavioural (NRI) correction procedure in patients with 
AUD. The present study aims exactly at this.
Methods
Participants and procedure
We used the patient group of the study in 2007 including 222 alcohol dependent 
inpatients admitted to the St Paschalis addiction treatment centre of the Dutch 
Vincent van Gogh Institute for Psychiatry. All patients were classified as alcohol 
dependent according to DSM-IV criteria and 76.6% of them were men. Mean age 
of the total group was 42.2 years (SD = 9.6). The DSM IV classifications were 
obtained based on extensive neuropsychiatric assessment including a clinical 
interview comprising the elements of the CPRS (Åsberg et al., 1978) conducted 
by an experienced neuropsychiatrist committed to the clinic. Patients performing 
below average intellectual abilities were excluded from participation in this 
research. Patients participated only after obtaining informed consent. They 
completed the Dutch version of the MMPI-2 after 14 days of abstinence as a part 
of the regular diagnostic process (2007). In order to systematically compare 
corrected with uncorrected MMPI-2 profiles, uncorrected scores, NRI-deleted 
scores, and NRI-prorated scores were computed. In the NRI-deleted procedure, 
the 24 NRI’s are discarded before scoring. In the NRI-prorated procedure, 
scoring was performed according to the description of Van Balen et al. (1999). 
Here, within each scale, the prorated raw score is estimated by 
(1) NNe + ( PNe × NNe / NN )
where NNe is the number of Non-NRI endorsements, PNe the patient’s NRI 
endorsement, and NN the total number Non-NRI endorsements. Because Alfano 
et al. (1990; Alfano et al., 1993) have successfully employed the deletion procedure 
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in patients with closed head injury and patients with neurologic dysfunction 
and since there are no prior studies about correction procedures in AUD patients, 
we decided to include both procedures in order to be able to compare them in 
the current study.
Measures
The MMPI-2 has been translated and standardized for Belgium and The 
Netherlands in 1993 (Derksen et al., 1993). Translation occurred according to 
international standards (Butcher, 1996). Internal consistency coefficients of the 
Clinical Scales are slightly lower in the Dutch normative sample than in the 
American normative sample. Cronbach’s alpha ranges from .31 (Scale 5 for 
women) to .85 (Scale 7 for men) with an average of .64. Test-retest reliability 
coefficients of the Clinical Scales range from .43 to .86, with an average of .69. The 
Dutch norms highly correspond with those of the American MMPI-2 (Butcher et 
al, 1989; Sloore et al, 1996). Detailed information about the psychometric 
properties of the Dutch-language version of the MMPI-2 and the translation 
process is presented in the new edition of the MMPI-2 manual (Derksen et al., 
2006). The validity of the Clinical Scales, Content Scales and PSY-5 Scales has 
been reported in relation to diverse Dutch clinical samples (Van der Heijden et 
al., 2010; Van der Heijden et al., 2008; Egger et al., 2003a; Egger et al., 2003b; Egger 
et al., 2003c; Derksen & de Mey, 1992; Vendrig, 1992).
Analysis
In line with the original study of Egger et al (2007), the NRI-corrected clinical 
scales are cluster analyzed in order to revisit the earlier described typology. 
Hierarchical cluster analysis of the Ward’s method of the mean centered profiles 
was performed according to the procedure as described by Morey (1991). In 
addition, frequency of code types will be recorded per cluster to analyse the 
changes caused by the correction procedure. 
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Results
Both NRI deleted and NRI prorated corrected mean MMPI-2 profiles are lower 
than the original mean profiles. After NRI deleted correction, significant 
differences with the original clinical scales 2, 3, 7, and 8, indicate less dysphoric, 
somatic and apathetic symptoms (medium effect sizes). A similar pattern is 
found after NRI prorated correction, where differences are significant on 3 
indicating lower levels of stress reactivity. Table 1 shows that the deleted 
correction procedure not only affects scales 1, 2, 3, 7, and 8, but also the other 
clinical scales. The results are summarized in Table 1. 
Table 1   Mean scale scores of the original, deleted and prorated scales in  
222 AUD patients
Original Deleted Prorated
MMPI-2 
Scale
Mean SD Mean SD Cohen’s d Mean SD Cohen’s d
L 46.53 9.61 46.53 9.61 - 46.53 9.61 a
F 73.69 21.54 70.82 20.82 .14 73.69 21.54  a
K 41.22 10.97 39.99 10.63 .11 41.22 10.97  a
1 60.58 14.90 59.22 12.42 .10 53.11 13.53 .53b
2 68.72 15.05 61.65 12.59 .51b 63.28 14.08 .37b
3 63.00 15.61 56.87 12.72 .43b 52.74 12.44 .73c
4 74.62 13.69 74.94 12.46 -.02 74.62 13.69  a
5 54.80 11.30 54.98 10.38 -.02 54.80 11.30  a
6 70.04 14.82 70.37 15.23 -.02 70.04 14.82  a
7 70.58 15.26 65.96 12.20 .33b 67.76 14.25 .19
8 70.29 15.85 64.25 12.61 .31b 65.83 14.17 .30b
9 62.37 13.95 60.15 12.96 .16 62.37 13.95  a
0 58.17 12.38 56.88 11.91 .11 58.17 12.38  a
Note. L= Lie, F= Infrequency, K= Correction, 1= Hypochondriasis, 2= Depression, 3= Hysteria, 4 = 
Psychopathic deviate, 5= Masculinity/ femininity, 6= Paranoia, 7 henia, 8= Schizophrenia, 9= Hypomania, 
0= Social Introversion. a The prorated correction procedure only affects clinical scales 1,2,3,7, and 8. b 
Medium effect size. c Large effect size.
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Cluster analysis of both NRI prorated and NRI deleted corrected profiles, reveals 
three clusters that show several significant differences, representing contrasting 
typologies of AUD patients compared to the original profiles (Table 2). While 
this is true for the clustering of both NRI prorated and NRI deleted data, the cluster 
profiles, however, share a prominent elevation of scale 4, indicating that 
impulsivity/disinhibition and lack of insight is at the core of all typologies.
Discussion and conclusion
This first study on the effect of neurobehavioural correction on MMPI-2 profile 
configuration of patients with AUD results in two important findings that, when 
not recognized, can easily lead to diagnostic drift and inadequate treatment 
planning. First, the decrease in scores of the corrected profiles as compared to 
the original ones, reflects the overrepresentation of somatic complaints and de-
moralizational beliefs during the “acute phase,” usually the first month of 
abstinence. This is in accordance with clinical observations in AUD patients 
during abstinence and earlier findings that these somatic complaints are merely 
a reflection of the patient’s multi-problem crisis that nearly always precedes 
admission to an addiction clinic (Schuckit, 2009; Becker, 2008; Bartels et al., 2007) 
producing elevations on MMPI-2 profiles (Allen, 1996; Dush & Keen, 1995; 
Forbey & Ben-Porath, 2007). 
 Second, although several “typologies” can be discerned in these patients, 
both impulsiveness/disinhibition and problems in self-reflective capacities, tend 
to dominate the clinical picture, which suggests that in all AUD patients, a 
fundamental process can be identified that is associated with the documented 
effects on brain functioning of (excessive) alcohol exposure (Crews, 2005; Kalivas 
& Volkow, 2005; Oscar-Berman & Marinkovic, 2007; Harper, 2009). 
Table 2   Code types of the original, NRI-deleted, and NRI-prorated MMPI-2 
profiles of 222 AUD patients, according to Graham (2006)
Cluster1 Cluster 2 Cluster 3
Correction 
method
N P Code type N P Code type N P Code type
Original 122 55 4 46 21 6-8 54 24 7-2-8
Deleted 92 42 4 85 38 6-4 45 20 4-9
Prorated 81 36 4-2 75 34 a 66 30 4-9
Note. P = percentage.a A well defined code type of the prorated MMPI-2 profile in cluster 2 is not present. 
Clinical scales 4,6,7, and 8 are all elevated.
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 There is a remarkable similarity between the here presented MMPI-2 profiles 
and those described by Dush and Keen (1995). Our current profiles show a 
prominent elevation of MMPI-2 clinical scale 4 representing impulsivity/
disinhibition, lack of insight, immaturity, irresponsibility, low motivation to 
change, and less environmental adaptivity (Graham, 2006). Impulsiveness is a 
common trait in AUD patients. It increases due to the toxic effect of alcohol on the 
prefrontal brain regions and causes, for instance, impaired decision making 
which, in turn, might affect treatment outcome (Bowden-Jones et al., 2005; Feil et 
al., 2010). As such, it is a major risk factor, a vulnerability, for the development of 
alcohol addiction (Fein et al., 2006b; Verheul et al., 1999). Earlier clinical, neuro-
pathological and neuroradiological studies found, along with the above 
mentioned effects of alcohol on the cortex, alcoholic cerebellar degeneration in 
more than 25 % of AUD patients (Atunez et al., 1998; Deshmukh et al., 2002; 
Linboe & Loberg, 1988; Torvik et al., 1982). The symptoms of alcoholic cerebellar 
degeneration resemble the symptom-complex known as the Cerebellar Cognitive 
Affective Syndrome (CCAS; Schmahmann & Sherman, 1998) and may be 
indicative for the contribution of the cerebellum in the process of modulating 
higher-order cognitive and emotional functions (Schmahmann, 2004; Fitzpatrick 
et al., 2008). 
 The impairments in social cognition in AUD patients, such as facial affect 
perception, emotional prosody, theory of mind, empathy, humor processing, 
self-awareness, interoception, and illness insight, are well documented 
(Uekermann & Daum, 2008; Goldstein et al., 2009; Volkow et al., 2011). That 
cognitive dysfunctions can influence self-report is also shown in a recent study 
with alcohol dependent patients by Lincoln et al (2011). They found impairments 
in the estimation and self-evaluation of past alcohol intake that could be 
attributed to verbal memory dysfunctions contingent upon chronic alcohol 
abuse. Moreover, a study with a homogeneous group of Korsakoff Syndrome 
patients, found deficits in a story comprehension task specifically caused by 
executive dysfunction (Oosterman et al., 2011). This implies that AUD patients, 
when filling out the 567 items of the MMPI-2, might as well be hampered by 
both the somatic complaints and reduced executive functioning during the 
acute phase of abstinence.
 In early abstinence, uncorrected MMPI-2 scales tend to reflect symptoms of 
withdrawal and cognitive recovery, overestimating levels of psychopathology, 
and tend to underrate disinhibitory behaviours and impulsive traits. The acute 
effects of alcohol withdrawal and the partial recovery of cognitive functioning 
over time, appears to be associated with the decrease of MMPI-2 scales, which 
can therefore not be merely attributed to the effects of treatment only. The latter 
is suggested by Polimeni, Moore and Gruenert (2010) but the absence of cognitive 
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parameters in their evaluation of treatment may limit their findings. Although 
one could argue that assessment should be postponed until most symptoms are 
in remission (e.g., Allen, 1996), clinically, the early availability of information on 
psychological and socio-emotional functioning is of great importance to 
effective treatment design. 
 Our findings suggest that in the acute phase of abstinence the withdrawal 
effects can easily lead to inadequate treatment planning, resulting in a more 
symptomatological approach. Such an approach (e.g., verbal group therapy for 
depression or anxiety and long psychotherapeutic sessions) is inadequate 
because it ignores the underlying cognitive deficits during the acute phase of 
abstinence and increases the risk of treatment drop out (Crews et al., 2005).
 Despite the fact that the NRI-correction procedure is originally developed 
for the assessment of patients with TBI (Van Balen et al., 1997), it appears to be a 
useful tool to disentangle “demoralisation” and cognitive deficits in AUD 
patients during abstinence. Deleting NRI’s from the item pool, however, 
compromises the integrity of the MMPI-2 (Edwards et al., 2003; Arbisi & 
Ben-Porath, 1999). Hence, Arbisi & Ben-Porath (1999) in their review on correction 
procedures, suggest that NRI’s must be scored in a different direction in order to 
obtain an accurate measure of psychopathology (prorated scoring). They also 
recommend caution in the clinical application of the correction procedure, 
especially when using the MMPI-2 to assess the presence of affective disturbances 
following head injury. The present study on the assessment of AUD patients 
during the acute phase of abstinence, underscores their warning and calls for 
the inclusion of more than one diagnostic measure when conducting treatment 
planning. 
 The use of an MMPI-2 prorated correction procedure in AUD patients is 
warranted in the acute phase of early abstinence to avoid diagnostic misinter-
pretations that may affect treatment. Relevant variables for better treatment 
planning can specifically be found within the neurocognitive domain (e.g., 
cognitive and emotional functioning) with the adoption of neuropsychological 
measures in the assessment of AUD patients.
Conclusions
This study supports the use of a neurocorrective approach on the MMPI-2 to 
enhance validity and reliability in AUD patients during the acute phase of 
abstinence. In using a well-documented correction procedure, we found that 
impulsivity and psychopathic deviation can be identified as a common denominator 
in this group of AUD patients. “Corrected” MMPI-2 assessment can, therefore, 
be helpful in the accurate identification of the above aspects and does justice to 
the effects of alcohol related cognitive deficits on the diagnostic process.
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 Given the adverse effects of alcohol on the entire brain resulting in a wide 
array of cognitive deficits associated with AUD, it is expected that the application 
of such a correction procedure would provide patient descriptives (profiles, 
code types) in greater detail, thus enabling more adequate treatment selection. 
In alcohol abuse treatment settings, validation studies are warranted to 
substantiate the relation between the NRI-correction procedure and relevant 
neuropsychological measures. Future studies must focus on investigating the 
validity of a correction procedure in AUD, its utility in treatment planning, and 
the role of underlying alcohol related cognitive deficits, such as problems in 
executive functioning, illness insight and personality traits in AUD patients 
during abstinence. 
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Chapter 6
Self-awareness of cognitive 
dysfunction: self-reported 
complaints and cognitive 
performance in patients with 
Alcohol-Induced Mild or  
Major Neurocognitive Disorder
Published as: 
Walvoort, S.J.W., van der Heijden, P.T., Wester, A.J., Kessels, R.P.C.,  
Egger, J.I.M. (2016). Self-awareness of cognitive dysfunction: self-reported 
complaints and cognitive performance in patients with Alcohol-Induced  
Mild or Major Neurocognitive Disorder. Psychiatry Research, 245, 291-296. 
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Abstract
Patients with Korsakoff’s syndrome (KS) typically have difficulties in recognizing 
the impact of their alcohol-related cognitive deficits on daily-life functioning. 
In this study, mean scores on self-reported complaints (measured with Minnesota 
Multiphasic Personality Inventory-2-Restructured Form; MMPI-2RF) and cognitive 
performance (measured with the Wechsler Adult Intelligence Scale-Third 
edition; WAIS-III; and the California Verbal Learning Test; CVLT) are compared 
between two matched patient groups with severe (KS) and mild alcohol-related 
cognitive disorders or non KS (NKS). KS patients demonstrate significantly 
lower scores on the WAIS-III indices and on the CVLT than the matched NKS 
group, and significantly higher scores on MMPI-2-RF validity scales that indicate 
denial of psychological complaints. Both groups are in the normal range on 
MMPI-2-RF Cognitive Complaints (COG) and Neurological Complaints (NUC) 
scales compared with the normative sample. Finally, self- reported complaints 
and cognitive performance are not correlated significantly in both groups. 
Despite their alcohol-related cognitive impairments, both groups report no 
cognitive complaints at all indicating self-awareness impairment. In addition to 
KS patients, also NKS patients are at risk that their apparently “without cognitive 
complaints” appearance on self-report questionnaires can be easily overlooked. 
These findings may have important clinical implications for diagnostic and 
treatment purposes. 
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Introduction
Alcohol use inhibits higher-order cognitive processes (executive functions), 
reducing the level of self-awareness leading towards increasing alcohol use 
(Goldstein et al., 2009). Eventually, in patients with Korsakoff’s syndrome (KS), 
the toxic effects of chronic alcohol misuse and thiamine deficiency on whole 
brain functioning are expressed in clinical, neurological, cognitive and 
pathological features of KS and Wernicke’s KS (Kopelman, 2002; Van Oort & 
Kessels, 2009). Impairments in memory and executive function (EF) are core 
symptoms of KS (Van Oort & Kessels, 2009), but are also present in patients 
without Korsakoff’s syndrome (NKS; Ihara et al., 2000; Oscar-Berman et al., 
2004; Loeber et al., 2009). Besides the cognitive dysfunction, specific behavior 
(e.g., apathy and impaired self-awareness) is found in KS patients, describing 
themselves on self-report questionnaires as having no problems at all, leading 
towards a “without complaints” appearance (Egger et al., 2002; Thomson et al., 
2012). 
 Cognitive dysfunction is already present in apparently healthy alcoholic 
patients (Bruijnen et al., 2013). In these patients lower cognitive performances on 
tests of memory and executive functioning are related to impaired self-
awareness, apathy, and unrealistic expectations in daily life affecting treatment 
compliance and increasing treatment drop-out rates (Bowden-Jones et al., 2005; 
Goldstein et al., 2009; Kornreich et al., 2001; Marinkovic et al., 2009; Noël et al., 
2002; Rinn, et al., 2002; Verdejo-Garcìa & Pérez-Garcìa, 2008). A better cognitive 
ability (e.g., IQ, executive function, and memory) is associated with metacognition 
(or knowing about knowing) leading towards a better self-awareness. Especially 
the ventral and dorsomedial prefrontal cortices are involved in reflective 
processing (David et al., 2012; Van der Meer et al., 2010) as well as the rostral 
anterior cingulate cortex (Moeller & Goldstein, 2014). These brain areas are also 
affected by the negative consequences of chronic alcohol use (Ratti et al., 2002; 
Moeller & Goldstein, 2014), resulting in impairments in facial affect perception, 
emotional prosody, theory of mind, and cognitive control over thoughts and 
behavior (Uekermann & Daum, 2008; Goldstein et al., 2009; Oscar-Berman et al., 
1990; Montagne et al., 2006; Wilcox et al., 2014). In addition, Shimamura and 
Squire (1986) found that metamemory (the knowledge that people have of their 
memory function) is impaired in KS patients, but not in patients with amnesia. 
Metamemory can be viewed as part of metacognition,  suggesting a link with 
executive functioning impaired in KS patients (Van Oort & Kessels, 2009). 
Moreover, metamemory impairment is also present NKS patients who evaluate 
their memory capacity just as good as healthy controls do (Le Berre et al., 2010). 
This finding is in line with self-report studies demonstrating that alcoholic 
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patients are inaccurate in estimating their own drinking behavior (Lincoln et al., 
2011). Consequently, NKS patients may underestimate their cognitive dysfunctions 
and, as a result, overestimate their cognitive capacities, which may lead to 
inadequate treatment. 
 Impaired self-awareness in alcoholic patients has never been investigated 
by means of comparing the outcome of self-reported cognitive complaints and 
cognitive performance tasks. This comparison is of interest for both the concept 
of illness insight and treatment utility in patients with Korsafkoff’s syndrome 
(KS) and in non Korsakoff’s syndrome (NKS) patients with alcohol-related 
cognitive dysfunction (ARCD). From a theoretical perspective, investigating 
the relationship between self-reported cognitive complaints and cognitive 
performance may provide more clarity on the concept of self-awareness. So far, 
no studies have been reported investigating this relationship empirically. 
Therefore, the aim of the present study is to investigate the relationship between 
self-reported cognitive complaints and cognitive performance in patients with 
Korsakoff’s syndrome (KS) and a matched group of non-Korsakoff patients 
(NKS) with ARCD.
 Based on Horton et al. (2014), Stavro et al. (2013), Segobin et al. (2015), and 
Egger et al. (2002), the following hypotheses were formulated in the current 
study: Because of the persistent nature of the cognitive dysfunctions found in 
several studies on alcohol-related cognitive dysfunctions, both patient groups 
(e.g., KS and NKS patients) are expected to report fewer cognitive complaints 
than the normative group, indicating impaired self-awareness. In comparing 
both groups a) H1 : KS patients report less cognitive complaints than NKS 
patients versus H0: both groups do not differ on reporting cognitive complaints. 
b) H1 : KS patients perform worse on cognitive performance tasks than NKS 
patients versus H0: both groups do not differ on cognitive performance tasks. c) 
Finally, we expect to find a correlation between cognitive performance (WAIS III 
scores and CVLT) and self-reported complaints (MMPI-2-RF). We expect that 
worse cognitive performance correlates with a lower illness insight resulting in 
less self-reported cognitive complaints on the MMPI-2-RF scales. H1 : There is a 
negative correlation between self-performance and self-reported complaints, 
and this negative correlation will be stronger in the KS group. H0: The negative 
correlation between self-performance and self-reported complaints do not differ 
between both groups.
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Method
Participants 
At the Centre of Excellence for Korsakoff and Alcohol-Related Cognitive 
Disorders, the main goal is to assess all admitted patients for alcohol-related 
cognitive dysfunction, ranging from Mild Neurocognitive Disorder to Major 
Neurocognitive Disorder (e.g., Korsakoff’s syndrome). Thirty-four KS patients 
were selected from an existing dataset (Wester et al., 2014) fulfilling the selection 
criteria described in Figure 1. Another 22 NKS patients with alcohol-related 
cognitive dysfunction were matched for age, sex, and level of education from the 
same dataset. The additional 12 patients were selected blind from an MMPI-2 
database. Selection was only based on the criterion that the NKS patients were 
matched with the KS patients on demographic variables (at group level), without 
any knowledge of test results, meeting the criteria described in Figure 1. All 
patients participated as part of a regular assessment procedure residing at the 
Centre of Excellence for Korsakoff and alcohol-related cognitive disorders of the 
Vincent van Gogh Institute for Psychiatry in Venray, the Netherlands. 
 In order to clarify the difference between both groups, the DSM 5 criteria 
were used in a retrospective way. The KS patients fulfill the DSM-5 criteria for 
Alcohol-Induced Major Neurocognitive Disorder (APA, 2013) including the 
presence of a persistent memory impairment resulting in severe deficits in social 
functioning, the absence of delirium or dementia due to a neurodegenerative 
disease, a history of alcohol-abuse disorder, evidence for a history of Wernicke 
encephalopathy, confabulation behavior ans history of malnutrition or thiamine 
defecit, as.established by neurologival, psychiatric, neuroradiological, and neu-
ropsychological examinations. None of the patients had any evidence for brain 
abnormalities that could account for their condition apart from atrophy or 
white-matter lesions associated with the chronic alcohol abuse and none fulfilled 
the proposed criteria for alcohol-related dementia (Oslin et al., 1998). None of 
the participants had hearing problems, language or communication deficits, 
or visual agnosia that could confound the performance on memory tests. 
The matched NKS patients had a history of chronic alcohol abuse with mild 
neurocognitive impairments and all met the DSM-5 criteria for alcohol-Induced 
Mild Neurocognitive Disorder (APA, 2013). The neurocognitive impairments 
were not due to another medical condition or use of other substances. In both 
groups, the cognitive deficits were substantiated by neuropsychological assessment. 
 Education level was assessed using 7 categories in accordance with the 
Dutch educational system (1 = less than primary school; 7 = university degree; 
Verhage, 1964). The modus of the education level was 4 (range 2-7 for both groups). 
Both samples consisted of 26 men and 8 women. Mean age was 55.5 years 
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(SD = 7.1). Both groups did not differ on their estimated verbal IQ (t (1) = .05, p = .82) 
assessed using the Dutch version of the National Adult Reading Test (NART; 
Nelson & Willison, 1991), and are comparable on their level of education (U = 577, 
p = .99). Mean lifetime of chronic alcohol consumption was 13.38 years (SD = 9.4) 
in the KS group and 13.94 years (SD = 8.5) in the NKS group. Although, all 
participants had no history of comorbid drug abuse or psychiatric disorders, 
all fulfilled the DSM-5 criteria for Tobacco Use Disorder. During the assessment 
process, apart from gait and balance abnormalities in patients with KS, no other 
relevant medical conditions were manifest.
Measures 
All participants completed a neuropsychological assessment and the Dutch 
language version of the MMPI-2 (Derksen, 2006) as part of the regular diagnostic 
process. The Minnesota Multiphasic Personality Inventory-2-Restructed Form 
(MMPI-2-RF; Ben-Porath & Tellegen, 2008; Ben-Porath, 2012; Tellegen & Ben 
Porath, 2008) scale scores were derived from the original MMPI-2 booklet 
administration (Van der Heijden et al., 2010). Detailed information about the 
Figure 1   Flowchart of the selection process of both patient groups.
Original dataset (Wester et al., 2014) N = 233
(KS: N = 136 KS; NKS : N =73; 24 cognitively unimpaired alcoholics)
KS: N = 51 
DATA of WAIS III, CVLT, MMPI-2RF present ? 
1
2
KS: N = 34  
3
KS : N = 34
4
MMPI-2-RF CNS-r raw score< 18, VRIN-r and TRIN-r T-scores < 80,
FP-r T-scores < less than 100, and  F-r T-score < 120
Blind matching of NKS patients on age, sex, level of education,
and criteria mentioned in point 2 and 3 
NKS: N = 22 from the existing set of Wester et al., 2014.
additional N = 12 from a MMPI-2 database
 
NKS : N = 34
5
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psychometric properties of the Dutch-language version of the MMPI-2-RF and 
the translation process is presented in the MMPI-2-RF manual (Van der Heijden 
et al., 2013). In the analysis three MMPI-2-RF validity scales (L-r, F-r, and K-r) and 
two MMPI-2-RF cognitive complaints scales were used. The L-r scale consists of 
14 items measuring uncommon virtues (e.g., item 182: “I am entirely self-
confident”), the F-r scale consists of 32 items measuring infrequent symptoms 
(e.g., item 46: “when I am with people I am bothered by hearing very strange 
things”), and the K-r scale consists of 14 items measuring adjustment validity 
(e.g., item 80: “I have a few quarrels with members of my family”). Both COG 
and NUC scales consist of 10 items each describing cognitive (COG; e.g., item 59: 
“my memory seems to be all right”) or neurological (NUC; e.g., item 162: “I 
seldom or never have dizzy spells”) complaints. Cronbach’s alphas for the NUC 
and COG scales are comparable with the normative data (i.e., .68 < Cronbach’s 
alpha < .78 which is considered acceptable; Ben-Porath & Tellegen, 2008; 
Nunnanly, 1978). 
 Cognitive performance was measured with the Dutch-language version of 
the Wechsler Adult Intelligence Scale – Third Edition (WAIS-III; Wechsler, 2005). 
The standardized index scores (M=100; SD= 15) were computed according to the 
Dutch test manual and used in the analysis. The Verbal Comprehension Index 
(VCI) consists of the subtests Vocabulary, Similarities, and Information. The 
Perceptual Organization Index (POI) consists of the subtests Block Design, 
Matrix Reasoning, and Picture Completion. The Working Memory Index (WMI) 
consists of Letter Number Sequencing, Digit Span, and Arithmetic. The 
Processing Speed Index (PSI) consists of the subtests Digit Symbol Coding and 
Symbol Search. The WAIS-III indexes are valuable in assessing cognitive 
impairment (Van der Heijden et al., 2012). Especially the PSI has proven to be 
sensitive in detecting acquired brain damage (Martin et al., 2000).
 To assess episodic memory, the Dutch-language version of the CVLT (Delis 
et al., 1987; Mulder et al., 1996) was used. The CVLT is a word-list learning test 
that has proven to be sensitive in detecting memory impairment in ARCD 
patients (Wester et al., 2014). The total CVLT raw score after five trials of 16 words 
(CVLT Total immediate recall) and the delayed free recall raw score after 20 
minutes (CVLT recall) were computed and are used in the analysis.
Procedure and analysis
All participants were recruited through Vincent van Gogh Institute for 
Psychiatry, and all data were collected as part of routine clinical assessment. The 
study was carried out in accordance with the Declaration of Helsinki and the 
Guidelines for Good Clinical Practice established by the International Conference 
on Harmonisation (CPMP=ICH=135=95) and approved by the Vincent van Gogh 
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Institutional Review Board (decision #66). The confidentiality of participants’ 
identities was maintained throughout the study process. Informed consent was 
obtained from all participants. To rule out withdrawal effects, both the neuro-
psychological assessment and the MMPI-2 were administered after patients had 
been abstinent from alcohol or other non-medical drugs for at least six weeks 
(Walvoort et al., 2013). Minimal length of abstinence was at least 42 days in both 
groups (range KS = 42 – 600 days); range NKS = 42- 180 days). In order to rule out 
reading problems, all participants were evaluated on their education level 
(at least fifth grade), in combination with the MMPI-2-RF VRIN-r <60 and TRIN-r 
< 60, as specified in the Manual for Administration, Scoring, and Interpretation 
(Ben-Porath & Tellegen, 2008). In this study, MMPI-2-RF profiles were considered 
valid if they had a CNS-r raw score of less than 18, VRIN-r and TRIN-r T-scores 
of less than 80, and FP-r T-score of less than 100, and a F-r T-score of less than 120 
(Ben-Porath & Tellegen, 2008). 
 SPSS version 22.0 was used for all of the statistical analyses. Table 1 presents 
descriptive statistics for both groups. A one-way ANOVA between both groups 
was conducted to compare the differences in mean scores on WAIS-III index 
scales (VCI, PRI, WMI, and PSI), CVLT total immediate and delayed recall scores, 
and MMPI-2-RF (K, L, F, COG, and NUC) scales. Bivariate correlations were 
computed between the aforementioned MMPI-2-RF scales, the WAIS-III Index scales, 
and the CVLT total immediate and delayed recall scores for both groups. In addition, 
to investigate if the obtained correlations between both groups were significant, 
Fisher’s Z-scores were computed. In computing the bivariate correlations, the 
uncorrected MMPI-2-RF raw scores are used in the statistical analysis (Tellegen 
& Ben-Porath, 2008; Butcher et al., 1995). The MMPI-2-RF raw scores were used 
because these are not affected by characteristics of the normative sample and 
thus comparable for different cultures (e.g., US and The Netherlands).
Results
As Table 1 indicates, the KS group demonstrates significantly lower scores on 
the WAIS-III indices (Perceptual Organization and Processing Speed) and the 
CVLT (immediate total score and delayed recall) than the matched NKS group. 
As to behavioral characterization and test taking attitude of both groups, 
notably, disorientation in space, time and person, and a more flattened curve on 
the five trials of the CVLT were found in KS patients. 
 KS patients demonstrate lower scores than NKS patients on the F-r scale and 
higher on the L-r and K-r scale, indicating an under-reporting bias. Both scores 
on the NUC and COG scales are within the normal range, suggesting that both 
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patient groups do not report more cognitive complaints compared to the 
normative data (M = 50, SD =10, N = 2150; Van der Heijden et al., 2013). 
 Overall, self-reported cognitive complaints did not correlate with the 
cognitive performance tasks (see Table 2). However, the COG scale correlated 
Table 1   Descriptives (mean scores, standard deviations,) of both groups  
on age, WAIS III indexes, CLVT raw scores, and MMPI-2-RF T-scores
NKS patients
N = 34
KS patients
N = 34
Mean SD Mean SD F value p value η
p
2
Age 55.94 6.78 54.91 7.51 F(1,66) = .35 .56 .00
WAIS III
VCI 90.44 15.01 85.47 15.16 F(1,66)  = 1.85 .18 .03
POI 91.38 16.53 84.06 12.00 F(1,66) = 4.37 .04 .19
WMI 90.12 13.33 86.38 14.82 F(1,66) = 1.19 .28 .02
PSI 89.50 14.48 75.94 13.56 F(1,66) =15.88 .00 .19
CVLT
Total score 38.41 12.33 29.88 10.77 F(1,66) = 9.22 .00 .12
Recall score 7.47 4.81 2.91 4.01 F(1,66) =18.00 .00 .21
MMPI-2-RF
F-r 70.88 
(6.26)
17.39
(3.82)
61.18
(4.15)
17.30
(3.81)
F(1,66) = 5.32 .03 .07
L-r 60.82
(4.82)
9.85
(2.05)
66.88
(6.09)_
10.13
(2.11)
F(1,66) = 6.25 .02 .09
K-r 43.91
(5.67)
8.18
(2.38)
49.47
(7.32)
10.34
(3.00)
F(1,66) = 6.05 .02 .08
NUC 63.59
(.53)
13.42
(.82)
58.32
(.95)
14.17
(.91)
F(1,66) = 2.48 .05 .04
COG 60.53
(.98)
14.88
(1.34)
54.44
(1.50)
12.59
(1.33)
F(1,66) = 3.32 .11 .05
Note. Mean scores and standard deviations of the MMPI-2-RF are T-scores; in parentheses are the raw 
scores; NKS = Alcohol-related cognitive dysfunction Non-Korsakoff; KS = Korsakoff’s syndrome; VCI = Verbal 
Comprehension Index; POI = Perceptual Organization Index; WMI = Working Memory Index (WMI); PSI = 
Processing Speed Index; F-r = Infrequent responses; L-r = Uncommon Virtues; K-r = Adjustment Validity; NUC 
= Neurological Complaints; COG = Cognitive Complaints; η
p
2 = partial eta squared; According to Miles & 
Shevlin (2001)  ηp
2 of .02 is regarded to be small; .13 =  medium; .26 = large.
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significantly with PSI in the KS group, indicating that more self-reported 
cognitive complaints are accompanied by a lower level of processing speed. The 
COG scale and PSI are not correlated in the NKS group and the correlations 
between COG and PSI significantly differ for both groups (i.e., Z = 1.78, p = .04). 
This specific correlation may be explained by a small number of outliers in the 
Korsakoff group (four cases). We found four patients who scored 2 SD above 
the mean (1 patient scored 2 SD above the mean PSI score, and 3 patients scored 
2 SD above the mean COG score). When those four cases are excluded from 
the analysis, the correlation between PSI and COG is no longer statistically 
significant.
Discussion and conclusion
This study is the first to investigate the relationship between self reported 
cognitive complaints and cognitive performance in two matched groups of KS 
and NKS patients. The MMPI-2-RF validity scales confirm the hypothesis that 
KS patients show denial and social desirability in self-reporting symptoms. 
In addition, no cognitive complaints on the MMPI-2-RF NUC and COG scales 
are being reported despite the cognitive dysfunctions in KS patients present on 
cognitive tests.
 Regarding cognitive complaints, both groups do not differ from those reported 
by a Dutch normative healthy sample. 
Table 2   Bivariate correlations between MMPI-2-RF raw scores, WAIS indexes, 
and the CVLT raw scores
VCI POI WMI PSI CVLT total CVLT recall
Total NKS KS Total NKS KS Total NKS KS Total NKS KS Total NKS KS Total NKS KS
L-r -.28* -.35* -.16 -.20 -.04 -.27 -.06 .05 -.09 -.33** -.20 -.27 -.15 -.15 .06 -.26* -.31 .06
F-r -.12 -.03 -.31 -.18 -.29 -.24 -.24* -.20 -.38* -.01 .04 -.35* -.14 -.32 -.19 .02 -.10 -.14
K-r .13 .16 .23 .11 .35* .04 .26* .25 .36* -.01 .19 -.11 .07 .36* .05 -.06 .19 -.00
NUC -.07 .08 -.28 -.11 -.12 -.22 -.08 -.06 -.15 -.33** -.20 -.27 .01 -.12 .01 .12 .01 .07
COG -.01 .09 -.21 -.20 -.04 -.27 -.06 .05 -.09 -.01 .04 -.35* -.05 -.02 -.31 .10 .15 -.24
Note. * p  < .05. ** p  < .01. ; BOLD = differences between Korsakoff and Alcohol-related cognitive dysfunction 
Non-Korsakoff are significant (p < .05); VCI = Verbal Comprehension Index; POI = Perceptual Organization 
Index; WMI = Working Memory Index (WMI); PSI = Processing Speed Index; CVLT total = Californian Verbal 
Learning Test total raw score; CVLT recall = Californian Verbal Learning Test recall raw score after 20 minutes; 
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 Compared to the NKS patients, KS patients perform significantly lower on 
PSI on the WAIS-III, but not on the COG scales in the MMPI-2-RF. This means 
that KS patients report the same amount of cognitive complaints than NKS 
patients, yet their speed processing capacity is lower. It was hypothesized that 
the severity of cognitive impairment would come with increased under-report-
ing of self-reported complaints. However, we did not find significant correlations 
between self-reported cognitive complaints and cognitive performance in both 
groups, except for the correlation between COG and PSI in the KS group. This 
particular correlation may be explained by a small number of outliers in the 
Korsakoff group (four cases).  
 In our study, the differences in the L-r/F-r/K-r score profile demonstrates a 
denial of psychological complaints and lower scores on infrequent complaints in 
the KS group. This under-reporting response style (i.e., L-r > F-r > K-r; trying to 
present themselves in a favorable way, Ben-Porath & Tellegen, 2008) is typical for 
KS patients (Egger et al., 2002). The combination of the L-r > F-r > K-r configuration 
and average scores on NUC and COG scales seems to be able to accurately detect 
the under-reporting tendency of KS patients underscoring the inclusion of 
validity scales in self-report questionnaires to ensure reliable responding. 
 KS patients perform significantly worse on processing speed, perceptual 
reasoning and memory performance than NKS patients. These findings support 
the notion that, in addition to the cognitive dysfunctions, a gradual process of 
impaired self-awareness would evolve in chronic alcoholic patients. This is in 
line with recent brain neuroimaging findings that showed a graded pattern of 
Table 2   Bivariate correlations between MMPI-2-RF raw scores, WAIS indexes, 
and the CVLT raw scores
VCI POI WMI PSI CVLT total CVLT recall
Total NKS KS Total NKS KS Total NKS KS Total NKS KS Total NKS KS Total NKS KS
L-r -.28* -.35* -.16 -.20 -.04 -.27 -.06 .05 -.09 -.33** -.20 -.27 -.15 -.15 .06 -.26* -.31 .06
F-r -.12 -.03 -.31 -.18 -.29 -.24 -.24* -.20 -.38* -.01 .04 -.35* -.14 -.32 -.19 .02 -.10 -.14
K-r .13 .16 .23 .11 .35* .04 .26* .25 .36* -.01 .19 -.11 .07 .36* .05 -.06 .19 -.00
NUC -.07 .08 -.28 -.11 -.12 -.22 -.08 -.06 -.15 -.33** -.20 -.27 .01 -.12 .01 .12 .01 .07
COG -.01 .09 -.21 -.20 -.04 -.27 -.06 .05 -.09 -.01 .04 -.35* -.05 -.02 -.31 .10 .15 -.24
Note. * p  < .05. ** p  < .01. ; BOLD = differences between Korsakoff and Alcohol-related cognitive dysfunction 
Non-Korsakoff are significant (p < .05); VCI = Verbal Comprehension Index; POI = Perceptual Organization 
Index; WMI = Working Memory Index (WMI); PSI = Processing Speed Index; CVLT total = Californian Verbal 
Learning Test total raw score; CVLT recall = Californian Verbal Learning Test recall raw score after 20 minutes; 
Total = Total sample  (n = 68); NKS = Alcohol-related cognitive dysfunction Non-Korsakoff (N = 34); KS = 
Korsakoff’s Syndrome (N = 34); F-r = Infrequent responses; L-r = Uncommon Virtues; K-r = Adjustment Validity; 
NUC = Neurological Complaints; COG = Cognitive Complaints. Data will be available upon request.
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cerebrospinal fluid enlargement, especially in the lateral ventricles and Sylvian 
fissures ranging from NKS to KS (Le Berre et al., 2015) where only the medial 
thalami, mammillary bodies, and corpus callosum are more severely damaged 
in KS patients (Pitel et al., 2012). This means that in addition to KS patients, also 
NKS patients are at risk that their apparently “without cognitive complaints” 
appearance on self-report questionnaires can be easily overlooked or mis-
interpreted as a lack of motivation by the therapist (Rinn et al., 2002) leading 
towards under diagnosis or inadequate treatment (Horton et al., 2014; Thomson 
et al., 2012). Studies in different patient groups show that self-report is moderately 
correlated with performance tasks (Carone & Ben-Porath, 2014; Gervais et al., 
2009), indicating that it is difficult to measure self-awareness impairment with self- 
report questionnaires only. Therefore, in addition to a heteroanamnesis, information 
on cognitive functioning is essential in the treatment of patient with chronic 
alcohol use. Cognitive functions can be measured accurately with relatively 
short cognitive screening tools, like the Montreal Cognitive Assessment test 
(MOCA; Nasreddine et al., 2005) in alcohol-dependent patients (Alarcon et al., 
2015) and in addicted patients (Bruijnen, et al., 2013; Copersino et al., 2009).
 A limitation of the present study is that information of a healthy control 
group and information regarding their cognitive performance on the neuro-
psychological tests used in the present study is lacking. Another limitation is 
that we did not measure the impairment in executive functions that affects 
self-awareness (Goldstein et al., 2009).
 In sum, the current study adds to the limited research on self-awareness in 
KS patients. For a better understanding of the concept of self-awareness and 
treatment of ARCD patients, more research is needed that focuses on measuring 
self-awareness and cognitive control in KS and NKS patients and investigates 
the effectiveness of cognitive rehabilitation programs, especially in NKS 
patients. In this perspective, cognitive rehabilitation studies of training cognitive 
control and working memory are promising (Bates et al., 2013; Kiluk & Carroll, 
2013). 
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Chapter 7
Measuring illness insight in 
patients with alcohol-related 
cognitive dysfunction 
using the Q8 questionnaire:  
A validation study
Published as: 
Walvoort, S.J.W., Van der Heijden, P.T., Kessels, R.P.C.,  Egger, J.I.M. (2016).  
Measuring illness insight in patients with alcohol-related cognitive 
dysfunction using the Q8 questionnaire: a validation study. 
Neuropsychiatric Disease and Treatment, 12, 1609–1615.
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Abstract
Impaired illness insight may hamper treatment outcome in patients with alco-
hol-related cognitive deficits. In this study, a short questionnaire for the 
assessment of illness insight  (e.g., the Q8) is investigated in patients with 
Korsakoff’s syndrome (KS) and Alcohol Use Disorder (AUD) patients with mild 
neurocognitive deficits. First, reliability coefficients are computed and internal 
structure is investigated. Then, comparisons are made made between patients 
with KS and patients with AUD. Furthermore, correlations with the DEX 
questionnaire are investigated. Finally, Q8 total scores are correlated with neu-
ropsychological tests for processing speed, memory, and executive function. 
Results show that the internal consistency of the Q8 was acceptable (i.e., 
Cronbach’s alpha = .73) The Q8 items represent one factor and scores differ 
significantly between AUD and KS patients. The Q8 total score, related to the 
Dysexecutive Questionnaire (DEX) discrepancy score and scores on neuropsycho-
logical tests as was hypothesized, indicates that a higher degree of illness insight 
is associated with a higher level of cognitive functioning.
 In sum, the Q8 is a short, valid and easy to administer questionnaire for 
assessing illness insight in patients with moderate and severe alcohol-related 
cognitive dysfunction.
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Introduction
Impairments in memory and executive function (EF) are core symptoms of 
Korsakoff’s syndrome (Van Oort & Kessels, 2009), but are also present in patients 
with alcohol use disorder (AUD) (Goudriaan et al., 2006; Ihara et al., 2000; 
Oscar-Berman et al., 2004; Loeber et al., 2009; McCrady & Smith, 1986). Both 
memory and EF are key features for a successful behavioral change to remain 
abstinent and to restore societal functioning (Blume & Marlatt, 2009; Crews et 
al., 2005; Le Berre et al., 2012; Tate et al., 2014). One consequence of these cognitive 
dysfunctions in patients with AUD is impaired illness insight (David et al., 2012; 
Goldstein et al., 2009). That is, patients typically underestimate the amount of 
alcohol they have used (Lincoln et al., 2011; Le Berre et al., 2010), and the duration 
of their alcohol addiction, but also misjudge the severe and adverse consequences 
of alcohol addiction on daily life and health functioning (Volkow & Li, 2005). 
Impaired illness insight can be regarded as a continuum ranging from total denial 
of the disease to more subtle metacognitive awareness deficits (David et al, 2012). 
Illness insight comprises awareness of illness, the capacity to view symptoms of 
the disease as pathological, and treatment adherence (David, 1990).
 In patients with Korsakoff’s syndrome (KS), overestimation of their memory 
abilities or a failure to recognize their severity is common due to impaired 
metamemory (Le Berre et al., 2010; Shimamura & Squire, 1986). Compared to the 
information given by the patients themselves, information given by relatives, 
therapists, and other professional caregivers report that these patients show 
poorer insight into and less awareness of their cognitive deficits (Verdejo-García 
& Perez-García, 2008). Impaired illness insight in alcohol-dependent patients 
might be related to their severe retrograde amnesia, including deficits in autobi-
ographical memory (Poncin et al., 2015).
 A wide network of brain structures has been identified as being crucial for 
self-awareness, and includes the prefrontal and posterior parietal cortex (Moeller 
& Goldstein, 2014; Prigatano & Johnson, 2003), the rostral part of the anterior 
cingulate cortex, the insula (Goldstein et al., 2009; Moeller & Goldstein, 2014), 
and the precuneus (Cavanna & Trimble, 2006). Typically, these brain areas are 
susceptible to the negative effects of alcohol use (Bates et al., 2002; Goldstein et 
al., 2009; Rosenbloom & Pfefferbaum, 2008; Sullivan & Pfefferbaum, 2005). While 
this would indicate that functional and structural changes in brain functioning 
underlie impaired illness insight, clinically, lack of illness insight is often 
misinterpreted as a motivational problem (Dean et al., 2015; Moeller et al., 2014) 
or alcoholic denial (Duffy, 1995; Rinn et al., 2002). Moreover, these alcohol-relat-
ed cognitive deficits can affect the results of self-report questionnaires in such a 
way that it can lead to clinical misinterpretation (Egger et al., 2002; Johnson-Greene 
88
et al., 2002; Lincoln et al., 2011; Walvoort et al., 2012). In order to avoid this 
misinterpretation of alcohol-related cognitive deficits, the combined use of 
self-report information and information reported by informants who know the 
patient very well, is essential for adequate diagnosis and in particular for the 
assessment impaired self-awareness. 
 Bourgeois and colleagues (2002a; 2002b) developed and validated a short 
questionnaire for measuring illness insight, the Q8 questionnaire, available in 
the French language. The Q8 is a short and easy to administer questionnaire for 
measuring illness insight by means of answering eight questions by the patient 
(see Appendix 1 for an English translation of the original French questions). 
After the patient has completed the Q8, a clinician who knows the patient very 
well rates each response with respect to its adequacy. The total score is the sum 
of the item scores (maximum = 8). A score of ≤ 2 indicates no illness insight; 
a score of 3 – 5 indicates poor illness insight and a score ≥ 6 indicates good illness 
insight. Bourgeois and colleagues examined the Q8 in a mixed-etiology 
psychiatric sample with severe psychopathology (e.g., patients with schizophrenia, 
bipolar depression, and addiction. However, despite of the fact that the Q8 was 
specifically designed for measuring levels of illness insight, until now, no 
research has yet been published about the use in patients with alcohol-related 
cognitive deficits.
 Therefore, in the present study we aim to investigate the psychometric 
properties of the Dutch language version of the Q8 in patients with severe 
and mild alcohol-related cognitive deficits. First, the internal consistency is 
investigated. Second, the internal structure is investigated. We expect all 8 items 
to represent one factor. Third, the difference in Q8 total scores between KS 
patients and AUD patients with moderate cognitive deficits is considered. We 
expect that KS patients have a lower Q8 total score than other AUD patients. 
Fourth, the Q8 scores are correlated with the Dysexecutive Questionnaire (DEX) 
discrepancy score, a widely used measure to assess daily executive problems in 
daily life as reported by the patient and an informant (Wilson et al., 1996). We 
expect that a lower DEX discrepancy score correlates with a lower Q8 total score 
indicating impaired illness insight. Finally, correlations of the Q8 with neuro-
psychological tests for executive functioning, memory, and processing speed 
are calculated. We hypothesize that impaired illness insight (i.e., a lower Q8 
total score) correlates higher with severe cognitive dysfunction in KS patients 
than in AUD patients with moderate cognitive deficits.
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Method
Participants 
All data were collected as part of routine outcome monitoring of clinical testing 
and all patients signed a treatment plan. The confidentiality of participants’ 
identities was maintained throughout the study process. The procedure was 
approved by the Vincent van Gogh Insitutional Review Board. The study was 
carried out in accordance with the Declaration of Helsinki and the Guidelines 
for Good Clinical Practice established by the International Conference on 
Harmonization (CPMP/ICH = 135/95). Ninety-seven patients completed the Q8 
as part of routine clinical assessment (see Table 1.). All were inpatients of the 
Centre of Excellence for Korsakoff and alcohol-related cognitive disorders of the 
Vincent van Gogh Institute for Psychiatry in Venray, the Netherlands. Forty-two 
patients were diagnosed as KS patients fulfilling the DSM-5 criteria for Alcohol- 
Induced Major Neurocognitive Disorder (APA, 2013) including the presence of a 
persistent memory impairment resulting in severe deficits in social functioning, 
the absence of delirium or dementia, a history of alcohol-abuse disorder, 
evidence for a history of Wernicke encephalopathy, confabulation behaviour, 
and history of malnutrition or thiamine deficit, as established by neurological, 
psychiatric, neuroradiological, and neuropsychological examinations. 
 The AUD group consisted of 55 patients with a history of chronic alcohol 
abuse with mild neurocognitive impairments. All AUD patients met the DSM-5 
criteria for Alcohol- Induced Mild Neurocognitive Disorder (APA, 2013). The 
neurocognitive impairments were not due to another medical condition or use 
of other substances. In both groups, the cognitive deficits were substantiated by 
neuropsychological assessment. 
 All patients were at least 42 days abstinent from alcohol at the time of 
testing. Education level was assessed using 7 categories in accordance with the 
Dutch educational system (1 = less than primary school; 7 = university degree; 
Verhage, 1964). No significant differences were found between the groups 
regarding sex distribution (χ2(1)= .000, p = .996). Descriptives of the total group 
(N=97) and differences between the Korsakoff (N = 42) and AUD patients 
(N = 55) are listed in Table 1.
Measures
Questionnaires
The Q8 has been developed and validated in French. For this study, the Q8 
(Bourgeois et al., 2002a; 2002b) was translated into Dutch and slightly adapted 
using the original French questions by a clinical neuropsychologist with expertise 
in alcohol related cognitive disorders (Dr. Arie Wester). Consensus was reached 
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in the translation by all authors. The resulting research version of the Q8 consists 
of eight questions (see Appendix 1), for example: “Do you experience limitations 
in your professional life, your family life, or in your social life?” and was 
administered five weeks after admission to the clinic. An internal consistency of 
0.81 was found in a previous study (Bourgeois et al., 2002a; 2002b).
 The DEX, a subtest of the Behavioural Assessment of the Dysexecutive 
Syndrome (BADS; Wilson et al., 1996) was administered. There are two versions; 
a patient rating scale (DEX-S) and a rating scale for informants (DEX-I; e.g., 
relatives, friends, or professional caregivers) who know the patient very well 
in relation to the daily activities/functioning. Both versions are 20-item scales 
in which each item is rated 0 = never, 1 = occasionally, 2 = sometimes, 3 = fairly 
often, or 4 = very often. The DEX incorporates cognitive, affective, and 
behavioural aspects of the dysexecutive syndrome. An example of such a 
question is “I find it difficult to keep my mind on something, and am easily 
distracted”. Both the patient and his/her primary professional caregiver from 
our department completed the DEX. In order to investigate the dissociation 
between self-report and behaviour, which is commonly seen in addiction 
(Goldstein et al., 2009), discrepancy scores for the DEX (DEX-D) were calculated 
by subtracting the informant scores from the self-ratings (David et al., 2012; 
Wilson et al., 1996). A negative discrepancy score indicates higher ratings by the 
patient than by the caregiver, suggestive of illness insight while a positive 
discrepancy score instead, points at a lower rating by the caregiver than by the 
patient and a lack of illness insight. Validity of DEX-D scores for detecting poor 
insight has been established previously. David and co-workers (2012) for instance 
found that DEX-D was highly discrepant in patients with Alzheimer and 
patients with brain injury and should be regarded as a measure of awareness of 
dysexecutive symptoms.
Neuropsychological measures
The Modified Six Elements Test (MSET) of the Behavioural Assessment of 
Dysexecutive Syndrome (BADS; Wilson et al., 1996) was used as a cognitive 
measure of daily executive functioning (Fernández-Serrano et al., 2010) and 
discriminates at a clinically significant level between KS and Non Korsakoff’s 
Syndrome patients (cf., Van Oort & Kessels, 2009; Maharasingam et al., 2013).
 The delayed free recall raw score of the Dutch version of the California 
Verbal Learning Test (CVLT; Delis et al., 1987) was used in the analysis. The 
CVLT is a word-list learning test that has proven to be sensitive in detecting 
memory impairment in chronic alcoholic patients (Wester et al., 2014; Walvoort 
et al., 2016). 
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 Finally, the Processing Speed Index (PSI) of the Wechsler Adult Intelligence 
Scale – Third Edition (WAIS-III; Wechsler, 2005) was used, which consists of 
the subtests Digit Symbol Coding and Symbol Search. The PSI has proven to 
be sensitive in detecting impairment in processing speed (Walvoort et al., 
submitted).
Procedure and analysis
Informed consents were obtained from all participants. The assessment of the 
DEX-questionnaires and the neuropsychological tests were administered after 
patients had been abstinent from alcohol or other non-medical drugs for at least 
six weeks (Walvoort et al., 2013). The neuropsychological tests were assessed by 
an experienced psychologist. In this study, the Q8 questionnaire was evaluated 
by an experienced clinical neuropsychologist who knows the patient well, two 
weeks prior neuropsychological assessment. Reliability of the Q8 was measured 
by computing Cronbach’s alpha and split half reliability. Internal structure of 
the Q8 is investigated by principal component analysis with varimax rotation. 
Parallel analysis was performed to determine the number of components that 
should be extracted (Glorfeld, 1995; Horn, 1965). Independent T-test’s were 
performed to measure differences between KS patients and AUD patients (see 
Table 1.). Pearson correlations coefficients were computed between the Q8, the 
DEX-S, DEX-I, DEX-D score, and the neuropsychological measures (MSET, CVLT 
and PSI) for both groups pooled together. 
Results
Cronbach’s alpha for the Q8 questionnaire is .73, a Spearman-Brown coefficient 
of .70, which are acceptable (Nunnally, 1978). PCA on the items in the total 
sample revealed one component accounting for 35% of the variance. PCA was 
repeated in both subsamples to investigate whether the factor structure was robust 
in both subsamples. In both subsamples one factor appeared with somewhat 
higher loadings in the KS subsample (M = .63) than in the AUD subsample 
(M= .47). The coefficient of congruence, used to compare the factors in both 
subsamples is .89. As a rule of thumb, Harman (1976) proposed that factors are 
congruent if the coefficient of congruence is equal to or greater than .94.
 As Table 1 indicates, the KS group demonstrated significantly lower scores 
on the Q8 questionnaire than the AUD controls. On the Q8, 64 % of the KS 
patients scored < 2 versus 23 % of the AUD controls. Table 2 demonstrates 
significant correlations between the Q8 and the DEX, CVLT recall, MSE, and PSI. 
Correlations of .10 are considered to be small, correlations of .30 can be considered 
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medium (Cohen, 1992). The positive correlations between Q8 and the DEX-S 
indicate that a higher level of illness insight is associated with a higher level of 
self-reported complaints on the DEX-S. Significant negative correlations between 
the Q8 and DEX-I were found, indicating that lower scores on the Q8 are associated 
with higher levels of observed dysexecutive symptoms by the informant. 
Moreover, the DEX-D score showed a positive correlation with the Q8, indicating 
that lower DEX-D scores (more symptoms observed by the professional caregiver 
than by the patient) are related with lower scores on the Q8. Positive correlations 
between the neuropsychological measures (MSET, CVLT, and PSI) and the Q8 
were found, revealing that better cognitive performance is associated with a 
higher level of illness insight. 
Discussion and conclusion
This study is the first in using the Q8 questionnaire in patients with severe and 
moderate alcohol-related cognitive dysfunction for assessing illness insight. 
Internal consistency, split-half reliability and factor analysis proved that the Q8 
has acceptable psychometric characteristics to assess (lack of) illness insight in 
patients with moderate to severe AUD.  The Q8 scores of KS patients differ from 
AUD patients with less severe cognitive impairments and the Q8 demonstrates 
medium correlations with the discrepancy score of the DEX (DEX-D), 
contributing to the concurrent validity of the Q8. These findings demonstrate 
the concurrent validity of the Q8 total score. Finally, as expected, better illness 
insight, as measured with the Q8, correlated with a better performance on 
measures of executive function (the MSET), memory (CVLT delayed free recall) 
and processing speed (PSI). 
 Since the Q8 incorporates self-reported thoughts and beliefs of the patient as 
well as an evaluation by a caregiver who knows the patient very well, it has 
Table 2   Pearson correlations between the Q8, the DEX, the CLVT,  
the MSET and PSI (N= 97)
DEX total score Neuropsychological measures
Self Informant Discrepancy CVLT delayed 
free  recall
MSET PSI
Q8 .26* -.30** .41** .28** .35** .26*
Note. * = P < .05; ** = p < .01; Discrepancy = DEX-Self minus DEX-Informant score; CVLT = California Verbal 
Learning Test; MSET = Modified Six Elements test; PSI = WAIS-III Processing Speed Index.
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clinical potential as a valid tool for assessing illness insight in patients with 
severe psychopathology. Since it comprises eight items, it has a shorter 
administration time than the DEX-D. In addition, the Q8 measures illness insight 
in a more direct way than the DEX-D. The DEX-D, being a measure of awareness 
in dysexecutive symptoms, is a more indirect way of measuring illness insight 
by comparing the “self” and “other” ratings (David et al., 2012). It should be 
noted that it is not always easy to gather information of relevant others, because 
the social network of AUD patients is often limited.
 Another limitation of the Q8 is that no data on test-retest reliability are 
available from the Bourgeois studies (2002a; 2002b) nor from the present study. 
Future research should address this and could also examine the use of the Q8 in 
addicted patients without cognitive dysfunction, as the addiction itself also 
affects illness insight and self-awareness (Goldstein & Volkow, 2011; Moeller & 
Goldstein, 2014; Verdejo-García & Perez-García, 2008; Volkow et al., 2012). Also, 
it would be interesting to evaluate the course of illness insight by assessing the 
Q8 on several occasions during abstinence. Kim et al., (2007), for instance, 
examined 117 male alcoholic patients up to one year of abstinence after treatment 
using a self-report questionnaire, and found that insight might improve during 
the course of abstinence. Alternatively, one could argue that this improved 
insight may be due to improved cognitive function, in line with findings that 
cognitive function in alcoholic patients recovers to some extent during abstinence 
(e.g., Stavro et al., 2013; Walvoort et al., 2013).
 In conclusion, the results of this study confirm that the Q8 questionnaire is 
a reliable and valid measure that provides a significant contribution to the 
assessment of illness insight in patients with moderate and severe alcohol-relat-
ed cognitive dysfunctions. It should be stressed, that the assessment of illness 
insight should always be performed by using different sources of information 
(e.g., neuropsychological measures, self-report questionnaires and information 
from professional caregivers) to further optimize clinical decision making and 
treatment selection.
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Summary and discussion
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Sum
m
ary and discussion
The main objective of this thesis is the multimethod evaluation of cognition 
and illness insight in patients with Alcohol Use Disorders (AUD). In this, an 
overview of the main findings of this thesis will be presented. Additionally, 
strengths and limitations will be discussed. Finally, clinical implications and 
directions for future research will be provided.
 
Main findings
In Chapter 2 the classification of alcohol-related cognitive deficits according to 
the DSM-5 (APA, 2013) was studied as compared to the DSM-IV TR (APA, 2000). 
The main conclusion is that the DSM-5 puts a greater focus on alcohol-related 
cognitive dysfunction, with an essential role for neuropsychological assessment for 
the classification, diagnosis of neurocognitive deficits, and for setting up 
treatment design and planning. Thus, neuropsychological testing is essential for 
evaluating the cognitive domains of functioning and to reveal cognitive 
strengths and weaknesses that guide treatment planning. 
 The timing of neuropsychological testing is important: if performed too 
early during abstinence, the effects of alcohol withdrawal can affect the 
assessment. Empirical evidence on the required period for abstinence before a 
reliable neuropsychological assessment of AUD patients can be carried out was 
reviewed and presented in Chapter 3. The aim was to come up with a suggestion 
regarding the abstinence time needed to perform a sound neuropsychological 
assessment. The literature review indicated that recovery to a relatively stable 
condition tends to take up three to five weeks. To ensure reliable neuropsycho-
logical assessment, an abstinence period of at least six weeks is recommended. 
During this six-week interval, the brain is allowed to regenerate and the patient’s 
physical state improves, allowing a more reliable assessment of the underlying 
neurocognitive and behavioural deficits for treatment purposes. 
 In setting up a proper psychological treatment design in AUD patients, 
self-report questionnaires are frequently used to obtain information about 
comorbid psychopathology and personality traits. However, chronic alcohol use 
and alcohol withdrawal may bias the outcome of self-report questionnaires in 
two ways. First, withdrawal effects of alcohol during abstinence may cause 
emotional and somatic discomfort that should be distinguished from other 
forms of (comorbid) psychopathology. Second, chronic alcohol use may lead to 
cognitive dysfunction and impaired illness insight affecting self- evaluations 
with questionnaires. One of the most frequently used psychological tests to 
evaluate personality and psychopathology in AUD patients, the Minnesota 
Multiphasic Personality Inventory (MMPI-2; Butcher, 1996), provides different 
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methods to adjust for these distorting effects of alcohol withdrawal and cognitive 
impairment on self-report. Chapter 4 systematically reviewed the literature to 
what extent the available MMPI-2 correction methods, originally developed for 
use in neurological patients, can be used in AUD patients during the acute phase 
(< 6 weeks) of abstinence. Results demonstrated that, given the similarity of 
cognitive deficits in patients with AUD and in those with Traumatic Brain Injury 
(TBI), the use of a MMPI-2 correction method can be helpful in the interpretation of 
psychopathology and personality profiles during the acute phase of abstinence. 
 In Chapter 5 the clinical utility of a particular MMPI-2 correction method 
(i.e., Van Balen et al., 1997) was empirically evaluated in a group of 222 AUD 
patients during the acute phase of abstinence (14 days). In this study, corrected 
and uncorrected profiles were compared. The result demonstrated that the 
decrease in scores of the corrected profiles, as compared to the original ones, 
reflected primarily an overrepresentation of somatic complaints and demora-
lizational beliefs during the acute phase of abstinence. This was in accordance 
with clinical observations and earlier findings that these somatic complaints 
were merely a reflection of the patient’s acute problems in multiple somatic, 
cognitive and behavioural domains. Such a state in itself produces elevations on 
MMPI-2 profiles and nearly always precedes admission to an addiction clinic. 
Furthermore, both impulsiveness/disinhibition and problems in self-reflective 
capacities dominated the differences between the corrected and uncorrected 
MMPI-2 scores in AUD patients. This suggests that uncorrected MMPI-2 scales 
tend to overstress psychopathology and to overlook disinhibitory personality 
traits caused by chronic alcoholism during the six weeks period of abstinence. 
Based on these findings, it is recommended to either delay the assessment with 
self-report questionnaires for at least six weeks or use the reported MMPI-2 
correction procedure during the acute phase of abstinence. 
 In Chapter 6 the concordance of self-reported cognitive complaints on the 
MMPI-2-RF with performance on cognitive tasks was examined to empirically 
evaluate the consequences of cognitive dysfunction and lack of insight. Two 
matched patient groups with severe and moderate alcohol-related cognitive 
dysfunction, i.e, fulfilling the criteria for Korsakoff’s syndrome (KS) and 
Non-Korsakoff cognitively impaired AUD patients, respectively, were used in 
this empirical evaluation. All 64 participants were tested after an abstinence 
period of at least six weeks. Regarding cognitive complaints, both groups did 
not differ from those reported by a Dutch normative healthy sample. In line with 
reported clinical features of KS patients (Egger et al., 2002), KS patients 
demonstrated denial and social desirability in self-reporting symptoms. In 
addition, KS patients did not report any cognitive and neurological complaints 
on the self-report questionnaire (i.e., the MMPI-2-RF cognitive and neurological 
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complaints scales) despite the evident dysfunction on cognitive performance 
tasks. Moreover, a typical MMPI-2-RF under-reporting response style in the KS 
group was found. All these findings appeared to be related with impaired 
illness insight. 
 In order to assess lack of illness insight in AUD patient with a different 
method, the psychometric characteristics of an illness insight questionnaire, the 
Q8, were investigated in Chapter 7. The Q8 is a short questionnaire for the 
assessment of illness insight by means of answering eight questions by the 
patient. After completion of the Q8, a clinician who knows the patient very well 
rates each response with respect to its adequacy. The utility of the Q8 in 97 AUD 
patients with mild (55 patients) to severe (42 KS patients) cognitive dysfunction 
was investigated. It was found that the Q8 is a reliable and valid measure for the 
assessment of illness insight in patients with AUD and severe comorbid psycho-
pathology. Better illness insight, as measured with the Q8, was related to a better 
performance on measures of executive function, memory and processing speed. 
Furthermore, the Q8 was able to discriminate between patients with and without 
Korsakoff’s syndrome contributing to the clinical diagnosis of Korsakoff’s 
syndrome. 
 In sum, by using a multimethod evaluation of psychopathology, cognitive 
complaints, cognitive functioning, and illness insight in patients with AUD, it 
can be concluded that (1) while DSM-5 classification necessitates the identification 
of cognitive deficits, additional neuropsychological assessment is obligatory to 
information about the neuropsychological domains of functioning; (2) it is 
preferred to apply an abstinence period of at least six weeks before neuro-
psychological testing and self-report questionnaires can be reliably administered; 
(3) knowledge of the obscuring effects effects of alcohol withdrawal, alcohol- 
related cognitive dysfunctions, and lack of illness insight on self- report 
questionnaires and cognitive functioning, will contribute to better understanding of 
AUD patients. All of this results in a more reliable and comprehensive profile of 
an individual’s weaknesses and strengths, in order to achieve a better treatment 
indication.
Strengths and limitations
A major strength of this thesis is that, by means of a multimethod evaluation, 
cognition and illness insight in AUD patients are examined from multiple 
perspectives to fill in the gaps in literature regarding the assessment issues. 
Moreover, specific patient groups with mild to severe cognitive dysfunctions are 
used, which are usually difficult to find for participation in clinical research. 
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Another major strength is that the results of the studies in this thesis lead 
directly to concrete recommendations for assessment and treatment planning in 
clinical practice. Furthermore, the studies in the present thesis use multiple 
measures. As a consequence, the conclusion regarding assessment of psychopa-
thology and cognitive functions in AUD patients is more sound as single method 
variance is avoided. 
 Some limitations also need to be considered. First of all, the studies in the 
current thesis did not include non-alcoholic control groups. One could argue 
that comparisons of the results with either a healthy control group or a group of 
non-alcoholic psychiatric patients may reveal how specific the pattern of 
cognitive dysfunction and reported complaints for AUD patients is. On the 
other hand, a broad variety of AUD patients with mild to severe psychopathol-
ogy were included in the current thesis, allowing a more dimensional approach 
to AUD-related problems. Another limitation might be that, even though an 
abstinence period of at least six weeks is recommended, this thesis provides no 
data regarding the assessment of AUD patients both at admission to the clinic 
and during six weeks of abstinence. By doing so, it becomes clearer whether the 
reported symptoms and complaints are associated with alcohol withdrawal or 
with alcohol- related cognitive disorders. Although a six-week abstinence period 
is warranted before a reliable neuropsychological assessment can be carried out, 
it must be noted that cognitive recovery varies greatly by individual 
(Oscar-Berman et al., 2014). Conversely, while in clinical practice it is common to 
assess patients according to a method of classification and categorization, this 
thesis demonstrates that assessment in a more dimensional way gives a better 
view of reality, providing more tools for treatment purposes. This corresponds 
with the way the DSM-5 conceptualizes alcohol-related cognitive deficits. 
Conclusions, clinical implications,  
and directions for future research 
In this thesis, a multimethod evaluation of cognitive complaints and illness 
insight in AUD is investigated. First by controlling for the effects of abstinence 
by using an abstinence period of at least six weeks and second by using multiple 
measurements for treatment purposes. Although this thesis focuses primarily 
on assessment and indication, some thoughts upon treatment utility and future 
research are presented. 
 The notion that cognitive deficits and impaired illness insight might be 
present in AUD patients will lead to more understanding of AUD patients. Neu-
ropsychological assessment should be highly recommended in assessing the 
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skills that are needed affected or still intact, for choosing suitable treatment 
goals for either cognitive rehabilitation training and/or (external) compensating 
techniques. Before neuropsychological assessment can take place, however, a 
patient must have been abstinent from alcohol for a period of at least six weeks. 
The combination of sustained abstinence and the effects of adequate nutrition 
and thiamine replacement have a positive effect on the recovery of cognitive 
functions. Moreover, patients with persistent AUD who already show cognitive 
problems and who do not receive thiamine replacement are at risk for developing 
chronic cognitive dysfunction, Wernicke’s encephalopathy, or even death (e.g., 
Thomson et al., 2013). Concerning the present findings it would be interesting to 
investigate, by means of repeated assessment, the alcohol-related cognitive 
deficits during the course of abstinence. By using multiple moments of testing a 
clinician can get a clear picture of the skills that may recover during treatment 
and can fine tune treatment strategies and set new treatment goals. Moreover, a 
study of Dennis et al. (2007) concluded that in addicted patients the risk of 
relapse is problematic during the first three years of abstinence, indicating that 
the application of an abstinence period and long-term strategies and programs 
should also be investigated for other types of addictive substances.
 Impaired awareness of cognitive deficits is associated with a lesser need to 
seek treatment, to set treatment goals, and to use learned skills to maintain 
abstinent of alcohol and other addictive substances (e.g., Rinn et al., 2002; 
Verdejo-Garcìa & Pérez-Garcìa, 2008). Although research is limited, this thesis 
investigated the use of an illness insight questionnaire (the Q8) in AUD patients 
with severe psychopathology. Since, the Q8 has not been studied in AUD 
patients without cognitive dysfunction, future studies should investigate if 
adjustment of the Q8 will detect impairment in illness insight at an early stage 
of addiction treatment in AUD and addicted patients without cognitive deficits. 
 The combination of self-report questionnaires (and correction methods; 
Chapter 5), performance tasks (Chapter 6), rating scales (self and others), and a 
systematic evaluation by clinician (Chapter 8) provides a broad picture of the 
patient’s cognitive and behavioural abilities leading to a more individualized 
treatment. By using a multimethod approach a clinician can interpret the 
reported complaints more accurate, reducing the risk of overburdening the 
patient during treatment, supporting the thought that self-awareness in AUD 
patients should not be confused with a lack of motivation. 
 Assessment of cognitive abilities before selecting a treatment will prevent 
the start of a treatment without the knowledge whether an AUD patient will 
actually benefit from it. By using a quick and easy to use cognitive screening 
instrument, such as the MoCA (Nasreddine et al., 2005), cognitive deficits can be 
detected in an early stage of treatment in AUD patients as well as in patients 
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with other substance use (e.g., Bruijnen et al., 2013; Copersino et al., 2009). 
From thereon, further investigation to assess neuro psychological domains of 
functioning or to design a proper treatment planning can start. In this view, the 
recent developed screening tool the BEARNI (Brief Evaluation of  Alcohol-Related 
Neuropsychological Impairments), especially designed for assessing alcohol- 
related cognitive deficits (Ritz et al., 2015) is promising, supporting the findings 
in this thesis that alcohol-related cognitive disorders should be taken into 
account during treatment. Moreover, although research is still limited, the 
expectation is that emotional functioning in AUD patients will improve if cognitive 
functioning recovers. 
 Future studies should focus on cognitive dysfunctions during the course of 
abstinence in AUD and other addictive substances by using cognitive screening 
tools, neuropsychological assessment, refining the illness insight scale for 
the use in AUD patients and in addicted patients, leading towards effective, 
personalized treatment interventions. 
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Appendix I   English version of the Q8 (adapted and translated from Bourgeois 
et al., 2002a). Copyright © 2002 Editions scientifiques et médicales 
Elsevier SAS. All rights reserved. Reproduced with permission. 
Q8 Questions Score
1. Why are you here? 
__________________________________________________
2. Do you feel that you are ill?  YES/NO
3. Which disease or disorder do you have?
__________________________________________________
4. What is the cause of this?
__________________________________________________
5.  Do you suffer psychologically or do you experience  
feelings of guilt?
 YES/NO
6. Do you experience limitations in your professional life,  
your family life, or in your social life? 
 YES/NO
7. How can we help you?
__________________________________________________
8. Do you think you can be treated? YES/NO
___________(0/1)
___________(0/1)
___________(0/1)
 
___________(0/1)
___________(0/1)
 
___________(0/1)
___________(0/1)
___________(0/1)
Q8 TOTAL SCORE ___________(0/8)
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In dit proefschrift worden zes studies beschreven met als doel om met behulp 
van verschillende methodes cognitie en ziekte-inzicht te evalueren bij de indicatie-
stelling van patiënten met alcoholgerelateerde cognitieve stoornissen. De methoden 
in dit proefschrift omvatten classificatie, zelfrapportage (inclusief correctie-
methoden), beoordelingsschalen, en neuropsychologisch testonderzoek waarbij 
rekening gehouden wordt met de abstinentietermijn die noodzakelijk is om de 
onthoudingseffecten van alcohol te minimaliseren. Allereerst wordt het begrip 
ziekte-inzicht nader uitgewerkt.
Alcohol, cognitie en ziekte-inzicht
Al enkele decennia is duidelijk dat langdurig overmatig alcoholgebruik een 
toxisch effect heeft op het functioneren van de hersenen en kan leiden tot 
cognitieve stoornissen (Crews et al., 2005; Harper, 2009; Kalivas & Volkow, 2005; 
McCrady & Smith, 1986; Oscar-Berman & Marinkovic, 2007). Deze cognitieve 
stoornissen uiten zich op de domeinen aandacht, geheugen, visueel spatiële 
functies en problemen in het executief functioneren, waaronder het probleem-
oplossend vermogen, de mentale flexibiliteit, de planning en de oordeels-
vorming (Bates et al., 2002; Goldstein et al., 2001; Scheurich, 2005). Doordat 
 behandelprogramma-onderdelen veelal een beroep doen op bovengenoemde 
cognitieve domeinen, is het niet verwonderlijk dat dergelijke behandelingen 
meestal niet succesvol zijn  (Allen et al., 1997; Manning et al., 2008; Scheurich, 
2005). Daarnaast is het belangrijk dat er gestreefd wordt naar abstinentie van 
alcohol. Tijdens abstinentie kunnen de alcoholgerelateerde cognitieve stoornissen 
(a) deels herstellen (Bates et al., 2002; Fals-Stewart et al., 1994; Loeber et al., 2009; 
Mann et al., 1999), (b) redelijk stabiel blijven over een periode van een jaar 
(Horton et al., 2015; Stavro et al., 2013) en (c) zelfs tot zes jaar later nog verbeteren, 
hetgeen het geval is voor het executief functioneren (Fein et al., 2006a; McCrady 
& Smith, 1986). De combinatie van het toedienen van thiamine (vitamine B1) en 
een normaal dieet is hierbij van doorslaggevend belang (Martin et al., 2003), 
waarbij het herstel samenhangt met leeftijd (Goldman, 1983), de abstinentietijd 
(McCrady & Smith, 1986) afgezet tegen de context van reeds bestaande cognitieve 
stoornissen, het opleidingsniveau en de persoonlijkheidskenmerken (Yücel et al., 
2007). Daarnaast is bekend dat alcoholgebruik een causaal verband heeft met het 
ontwikkelen van angst en depressie, en ook dat  aanwezige psychopathologie en 
persoonlijkheidstrekken de kans op alcoholverslaving vergroten (Verheul et al., 
1999). Hoewel de literatuur aantoont dat bij langdurig alcoholgebruik ook de 
sociaal-cognitieve functies (waaronder perspectiefname, oordeelsvorming, zelf - 
bewustzijn en ziekte-inzicht) zijn aangetast (Uekermann & Daum, 2008; Moeller 
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& Goldstein, 2014), wordt hier nog onvoldoende rekening mee gehouden in de 
diagnostiek en de daaropvolgende behandelfase. 
 Een tekort aan ziekte-inzicht, ook wel anosognosie genoemd (Babinski, 1914), 
wordt gezien bij patiënten die geen weet hebben van de eigen ziekte en daarmee 
ook geen noodzaak zien om in behandeling te gaan. Crosson et al. (1989) waren 
de eersten die een trapsgewijs model voor ziekte-inzicht hebben ontwikkeld 
bestaande uit drie niveaus. Het eerste niveau is dat van het intellectueel besef, 
ofwel het kennen van de eigen beperkingen; het tweede niveau  betreft het besef 
van zowel de eigen beperkingen alsmede het compenseren hiervoor; en het 
derde niveau wordt gedefinieerd door het besef van de eigen beperkingen, de 
compensatiemogelijkheden en tevens de vaardigheid om te kunnen anticiperen. 
Het derde niveau vereist intacte planningsvermogens en metacognitieve 
vaardigheden. Dit trapsgewijze model is door Van Schouwen-van Kranen (2014) 
verder uitgewerkt. Hierbij is het model van Crosson et al. (1989) geïntegreerd 
met een hiërarchisch model van cognitief functioneren, met aandacht als basale 
vaardigheden, gevolgd door geheugen, en tot slot de executieve functies (planning) 
als meest complexe cognitieve functie (Allen et al., 1992). In dit hiërarchisch 
georganiseerde model correspondeert de hoogte van het cognitief functioneren 
met de mate van ziekte-inzicht, variërend van laag cognitief functioneren en beperkt 
tot geen ziekte-inzicht tot en met hoog cognitief functioneren en ziekte-inzicht. Deze 
inzichten werden bevestigd door studies die aantonen dat de mate van ziekte- 
inzicht varieert van een totale ontkenning van de eigen problematiek tot subtielere 
metacognitieve problemen (David et al., 2012). Problemen met ziekte-inzicht 
komen onder meer voor bij patiënten met neurodegeneratieve aandoeningen 
(Shany-Ur et al., 2014), niet-aangeboren hersenletsel (Ham et al., 2014), schizofrenie 
(Kruck et al., 2009), en verslavingsproblematiek (Moeller & Goldstein, 2014). 
Bij patiënten met alcoholgerelateerde cognitieve stoornissen wordt vaak een tekort 
aan initiatiefname, een beperkt ziekte-inzicht, apathie en verstoorde executieve 
functies gevonden (Marinkovic, et al., 2009)., waarbij een beperkt ziekte-inzicht 
niet verward moet worden met een gebrek aan motivatie (Miller & Barasch, 
1985; Rinn et al., 2002). 
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Naar een meervoudige evaluatie van 
alcoholgerelateerde cognitieve stoornissen 
Alcoholgerelateerde cognitieve stoornissen zijn moeilijk te classificeren middels 
de DSM-IV TR (APA, 2000) en kunnen bijgevolg leiden tot zowel overschatting 
als onderschatting van de (onderliggende) cognitieve stoornissen in de klinische 
praktijk. Het is dus van belang dat voorafgaand aan de behandeling duidelijk 
moet zijn welke cognitieve vaardigheden intact zijn en welke niet. Bij het opstellen 
van een dergelijk sterkte- en zwakteprofiel kan een behandelaar een aantal 
problemen tegen komen die het beeld kunnen vertroebelen, zoals de invloed 
van abstinentie op het herstel van cognitieve stoornissen en de invloed van 
het beperkt ziekte-inzicht en cognitieve stoornissen op de uitkomsten van zelf-
rapportagevragenlijsten. 
 Om duidelijkheid te kunnen krijgen over de manier waarop alcoholgerela-
teerde cognitieve stoornissen het best kunnen worden geclassificeerd in DSM- 
termen, werd in hoofdstuk 2 de classificatie van alcoholgerelateerde cognitieve 
stoornissen volgens de DSM-5 (APA, 2013) vergeleken met die volgens de DSM-IV 
TR (APA, 2000). De belangrijkste conclusie uit deze studie is dat  alcoholgerelateerde 
cognitieve stoornissen in DSM-5-termen beter geclassificeerd kunnen worden, 
omdat hierin een prominente rol is weggelegd voor neuropsychologisch onderzoek. 
 De timing van een dergelijk neuropsychologisch onderzoek is belangrijk: 
als neuropsychologisch onderzoek te vroeg tijdens de abstinentieperiode wordt 
uitgevoerd, kunnen de alcoholgerelateerde onthoudingseffecten zowel de uit- 
komsten beïnvloeden van (zelfrapportage)vragenlijsten, van neuropsychologische 
testen,  alsook van de behandeling. In hoofdstuk 3 is gezocht naar wetenschappelijk 
bewijs aangaande de abstinentietijd die nodig is om betrouwbaar neuropsycho-
logisch onderzoek uit te kunnen voeren bij patiënten met stoornissen in alcohol-
gebruik. Het doel van deze studie was om met een voorstel te komen wanneer 
neuropsychologische onderzoek het best uitgevoerd zou kunnen worden. De 
bestudeerde wetenschappelijke literatuur toonde wisselende termijnen van 
cognitief herstel variërend van drie tot vijf weken abstinentie. Om betrouwbaar 
neuropsychologisch onderzoek uit te kunnen voeren werd een abstinentietermijn 
van minimaal zes weken voorgesteld. Gedurende deze zes weken ontwikkelt 
het cognitief functioneren zich tot een relatief stabiel niveau, waardoor betrouw-
baarder onderzoek naar cognitieve mogelijkheden en beperkingen uitgevoerd 
kan worden. 
 Voor psychologische behandeldoeleinden wordt in de verslavingszorg frequent 
gebruik gemaakt van zelfrapportagevragenlijsten. Op deze manier kan informatie 
verzameld worden over aanwezige psychopathologie en persoonlijkheidstrekken. 
Echter, chronisch alcoholgebruik en alcoholonttrekking kunnen de uitkomsten 
132
van deze vragenlijsten op twee manieren vertroebelen. In de eerste plaats kunnen 
alcoholonthoudingseffecten emotionele en somatische klachten veroorzaken die 
tijdens de acute fase van abstinentie moeilijk te onderscheiden zijn van 
(comorbide) psychopathologie. In de tweede plaats kan chronisch alcoholgebruik 
leiden tot cognitieve stoornissen en een verminderd ziekte-inzicht, die de 
uitkomsten van dergelijke vragenlijsten kunnen beïnvloeden. Een van de meest 
gebruikte en wetenschappelijk onderzochte zelfrapportagevragenlijsten om 
persoonlijkheidstrekken en psychopathologie bij mensen met een alcoholversla-
ving te meten is de Minnesota Multiphasic Personality Inventory (MMPI-2; 
Butcher, 1996). Voor de MMPI-2 zijn onder meer voor neurologische patiënten, 
een aantal methodes beschreven om te corrigeren voor de verstorende effecten 
van hersenletsel op de MMPI-2. In hoofdstuk 4 is de literatuur systematisch 
onderzocht met de vraag in hoeverre de voorhanden zijnde MMPI-2 correctie-
methodes toepasbaar zijn voor patiënten met stoornissen in alcoholgebruik 
tijdens de eerste fase van abstinentie (< 6 weken). Uit de resultaten blijkt dat, 
gezien de overeenkomst tussen cognitieve stoornissen bij patiënten met 
stoornissen in het gebruik van alcohol en patiënten met traumatisch hersenletsel, 
het gebruik van een correctiemethode voor de MMPI-2 ondersteunend kan zijn 
bij het interpreteren van psychopathologie en persoonlijkheidstrekken tijdens 
de eerste fase van abstinentie. 
 In hoofdstuk 5 is het gebruik van een correctiemethode voor de MMPI-2 
(ontwikkeld door Van Balen et al., 1997) empirisch geëvalueerd bij een groep 
van 222 patiënten met stoornissen in het gebruik van alcohol tijdens het begin 
van abstinentie (de eerste 14 dagen). Uit de vergelijking van gecorrigeerde en 
ongecorrigeerde MMPI-2-profielen komt naar voren dat correctie de gerapporteerde 
somatische klachten en demoralisatie, die doorgaans voorkomen tijdens de 
beginfase van abstinentie, kan verlagen. Dit komt overeen met de klinische 
observaties en eerdere bevindingen dat de somatische klachten het acute 
klinische beeld kunnen bepalen en daarmee de cognitieve en gedragsmatige 
problemen overschaduwen. Daarnaast toont de studie aan dat ongecorrigeerde 
MMPI-2- schalen sterk de nadruk leggen op ernstige psychopathologie waardoor 
specieke trekken als disinhibitie en problemen met zelfreflecterend vermogen 
gemakkelijk als onderliggende factoren over het hoofd worden gezien. Kortom, 
gebaseerd op deze bevindingen wordt voorgesteld om het testonderzoek uit te 
stellen tot minimaal zes weken abstinentie of anderszins een MMPI-2-correctie-
procedure toe te passen tijdens de acute fase van abstinentie. 
 In hoofdstuk 6 is de relatie tussen zelfgerapporteerde cognitieve klachten, 
gemeten met de herziene versie van de MMPI-2, de MMPI-2-RF, en de prestaties 
op cognitieve taken onderzocht door twee vergelijkbare patiëntgroepen met 
ernstige (korsakovsyndroom) en matige neurocognitieve stoornissen door alcohol 
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met elkaar te vergelijken. De 64 deelnemende patiënten zijn getest na een absti-
nentietermijn van minimaal zes weken. Zoals verwacht rapporteerden korsa-
kovpatiënten geen cognitieve of neurologische klachten op de zelfrapportage 
vragenlijst (MMPI-2-RF) terwijl er sprake was van evidente cognitieve 
stoornissen middels neuropsychologische tests. Dit lijkt overeen te komen met 
de klinische kenmerken van korsakovpatiënten, zoals ontkenning van de eigen 
klachten en sociaal wenselijk gedrag (Egger et al., 2002). Bovendien werd er in de 
groep korsakovpatiënten een MMPI-2-RF-antwoordtendentie gevonden die 
kenmerkend is voor de onderrapportage van klachten. Daarnaast bleek dat 
beide groepen niet van elkaar verschilden ten aanzien van de zelfgerapporteer-
de cognitieve klachten. Beide groepen rapporteerden ongeveer evenveel 
cognitieve klachten als de gemiddelde Nederlander (de normgroep van de test), 
terwijl er veel meer cognitieve problemen werden gezien op neuropsychologi-
sche tests. Deze bevindingen lijken samen te hangen met een beperkt ziekte-
inzicht. 
 Om ziekte-inzicht bij patiënten met stoornissen in het gebruik van alcohol 
vast te kunnen stellen zijn in hoofdstuk 7 de psychometrische aspecten van een 
vragenlijst gericht op ziekte-inzicht (de Q8; Bourgeois et al., 2002a; Bourgeois et 
al., 2002b) onderzocht. De Q8 is een korte vragenlijst bestaande uit acht vragen 
die door de patiënt ingevuld moeten worden. Na het invullen van deze lijst 
worden de Q8-items beoordeeld op hun adequaatheid door een clinicus die de 
patiënt goed kent. De toepasbaarheid van de Q8 is onderzocht in een groep van 
in totaal 97 patiënten met matige (55 patiënten) tot ernstige (42 patiënten met het 
syndroom van Korsakov) alcoholgerelateerde cognitieve stoornissen. De Q8 
bleek een betrouwbaar en valide instrument is om de mate van ziekte-inzicht 
vast te kunnen stellen bij patiënten met stoornissen in het gebruik van alcohol 
met comorbide ernstige psychopathologie. Een beter ziekte-inzicht (een hogere 
Q8-totaalscore) lijkt samen te hangen met betere prestaties op taken die executief 
functioneren, geheugen en verwerkingssnelheid meten. Daarnaast is de Q8 in 
staat om onderscheid te maken tussen patiënten met ernstige cognitieve 
stoornissen (Korsakov) en matige cognitieve stoornissen, waarmee het een 
bijdrage levert aan de klinische diagnose van het syndroom van Korsakov. 
Tot besluit
Samenvattend, door gebruik te maken van een meervoudige (“multimethode”) 
evaluatie van psychopathologie, cognitieve klachten, cognitief functioneren en 
ziekte-inzicht bij patiënten met alcoholgerelateerde (cognitieve) stoornissen 
kunnen de volgende conclusies getrokken worden: (1) waar de DSM-5 classificatie 
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bijdraagt aan de identificatie van cognitieve stoornissen, is het neuropsychologisch 
onderzoek een onmisbaar onderdeel om informatie te vergaren over de neuro-
psychologische cognitieve domeinen voorafgaand aan de behandeling; (2) een 
abstinentietermijn van minimaal zes weken moet in acht genomen worden 
voordat neuropsychologisch onderzoek en zelfrapportagevragenlijsten betrouwbaar 
kunnen worden afgenomen en geïnterpreteerd; (3) kennis van de vertroebelende 
effecten van alcohol onthouding, onderliggende alcoholgerelateerde cognitieve 
stoornissen en een beperkt ziekte-inzicht op zelfrapportagevragenlijsten en het 
functioneren kan leiden tot een beter begrip van deze doelgroep. Door een 
multi methodische evaluatie kan er een betrouwbaar cognitief profiel worden 
opgesteld met sterktes en zwaktes van de patiënt, waarmee de behandeling 
beter en effectiever kan worden ingericht. Door het opnemen van meerdere 
meetmomenten tijdens de behandeling kan er een duidelijk beeld verkregen 
worden van de vaardigheden die herstellen tijdens de abstinentie en behandeling. 
Op deze wijze kan de behandelaar de behandeling verfijnen en is de verwachting 
dat deze (geïndividualiseerde) behandelaanpak de kans op overvraging en het 
voortijdig afbreken van de behandeling verkleint.
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the Donders Graduate School for Cognitive Neuroscience (DGCN), which was officially 
recognised as a national graduate school in 2009. The Graduate School covers training at 
both Master’s and PhD levels and provides an excellent educational context fully aligned 
with the research programme of the Donders Institute.
The school successfully attracts highly talented national and international students in 
biology, physics, psycholinguistics, psychology, behavioral science, medicine and related 
disciplines. Selective admission and assessment centers guarantee the enrolment of the best 
and most motivated students.
The DGCN tracks the career of PhD graduates carefully. More than 50% of PhD alumni show 
a continuation in academia with postdoc positions at top institutes worldwide, e.g., Stanford 
University, University of Oxford, University of Cambridge, UCL London, MPI Leipzig, 
Hanyang University in South Korea, NTNU Norway, University of Illinois, North Western 
University, Northeastern University in Boston, ETH Zürich, University of Vienna, etc. 
Positions outside academia spread among the following sectors: specialists in a medical 
environment, mainly in genetics, geriatrics, psychiatry and neurology; specialists in a 
psychological environment, e.g., as specialist in neuropsychology, psychological diagnostics 
or therapy; positions in higher education such as coordinators or lecturers. A smaller 
percentage enters business as research consultants, analysts or head of research and 
development. Fewer graduates stay in a research environment as lab coordinators, technical 
support or policy advisors. Upcoming possibilities are positions in the IT sector and 
management position in pharmaceutical industry. In general, the PhDs graduates almost 
invariably continue with high-quality positions that play an important role in our knowledge 
economy.
For more information on the DGCN as well as past and upcoming defences, please visit: 
http://www.ru.nl/donders/graduate-school/donders-graduate/
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